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INTRODUCTION 
 
 Siddha medicine is the ancient system of medicine practiced in southern India.  
The origin of Tamil language is attributed to the sage Agasthiar and the origin of Siddha 
medicine is also attributed to him. Before the aryan, there existed an organized 
civilization in the southern India.  This civilization has a medicine to deal with problems 
of sanitation and treatment of diseases. This is the Siddha system of medicine. The 
therapeutics of Siddha medicines consists of the use of metals and minerals. 
 
 The Tridosha theory, Sapta Dhatu physiology and nomenclature of the diseases are 
unique in the Siddha medicines. Traditionally it is said that there were 18 Siddhars. They 
left their imprint not only in medicines but also in yoga and philosophy. The Siddhars 
were essentially yogis and secondarily physicians. 
 
 The fundamental principles of Siddha medicines consists of two essential entities, 
matter and energy. The Siddhars call them Siva (Male) and Sakthi                  (Female, 
creation) matter cannot exist without energy inherent in it and vice versa. They are the 
primordial elements Bhutas.  They are Mann (Solid), Neer(fluid) , Thee (radiant) 
Vayu(gas) and Aakasam(ether). These 5 elements are present in every substance, but in 
different proportions. 
 
 The human anatomy and physiology, causative factor of diseases, the materials for 
the treatment and cure of diseases, the foods for sustenance of the body, all fall within the 
5 elemental categories. The human being is made up of these 5 elements, in different 
combinations. When their equillibrium is upset disease sets in. 
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 Madhumegam (Diabetes Mellitus) is the most common of the serious metabolic 
diseases of humans. It is characterized by hyperglycemia with or without glycosuria 
resulting from absolute or relative deficiency of insulin. Lack of insulin affects the 
metabolism of carbohydrate, protein and fat and causes a significant disturbance of water 
and electrolyte homeostasis. 
 
 Madhumegam (Diabetes) is world wide in distribution and the incidence of both 
Type I ( Insulin dependent) and Type II (Non Insulin dependent) diabetes is rising. It is 
estimated that in the year 2000,150 million people world – wide had diabetes and this is 
expected to double by 2010. This global pandemic principally involves Type II diabetes, 
and is associated with several contributory factors including obesity, unsatisfactory diet, 
sedentary lifestyle and increasing urbanisation. However the prevalence of both types of 
diabetes varies considerably around the world and is related to differences in genetic and 
environmental factors. 
 
 The disease is characterized by a series of hormone-induced metabolic 
abnormalities, by long term complications involving the eyes, kidneys, nerves and blood 
vessels. 
 
 Hence an effort is made to bring effective medicine from the herbal kingdom for 
treating this global disease. 
 
 The present study of Attiverpattai choornam is tried for Madhumegam and its 
therapeutic efficacy is found out by pharmacological studies and clinical trial supporting 
the study had been made out. 
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AIM AND OBJECTIVES 
 
AIM  
 To evaluate the efficacy of Attiver Pattai Chooranam (Ficus racemosa) in the 
management of  Madhumegam.   
 
OBJECTIVES:  
 
 To Identify the Crude drug  
 To study the Antimicrobial activity of the drug 
 Bio Chemical analysis of the drug  
 To study the Acute oral toxicity of the drug  
 To study the Pharmacological activity  of the drug (Anti-diabetic)  
 To evaluate the efficacy of the drug clinically  
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BOTANICAL ASPECT 
 
BOTANICAL NAME :  
 
 Ficus racemosa linn  
 Ficus glomerata roxb 
 
SYNONYMS   
 Tamil   -    Atti  
 English   -    Gular Fig, Cluster fig, Country fig.  
 Hindi   -  Gular, Umar  
 Beng   - Dumur, Jagyadumtar  
 Guj   -  Umar, Gular , Umbar  
 Mal  -  Atti  
 Tel   -  Udambaaramu  
 Sanskrit  -  Udambara  
 Urdu  -  Gular  
 
BENTHAM & HOOKERS CLASSIFICATION 
 
 Kingdom  -  Plant Kingdom  
 Division  -  Phenarogams  
 Class  -  Dicotyledons  
 Subclass - Monochlamydae  
 Series  -  Unisexuales  
 Family  - Moraceae  
 Genus  - Ficus   
 Species  -  racemosa  
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BOTANICAL DESCRIPTION:38  
 
 An evergreen tree 15-18m high. Young shoots glabrous, pubercent or scaberutous.   
 
Leaves:  
 7.5-15 by 3.2 – 6.3 cm  
 Ovate – oblong or elliptical – Lanceolate, tapering to a bluntish point at the apex.  
Glabrous on both surface when mature. Base acute or rounded, 3-neverd petioles 
1.3 – 3.8 cm long, glabrous  
Stipules 2 cm long ovate, scarious  
 
Flowers :  
Male, females and gall flowers together in one receptacle.  
Male flowers sessile sepals 3-4 membranous, inflated enveloping the 2 elongate 
ovate anther  
Gall flowers pedicellate.  
 
Perianth :  
 Gamophyllous, Irregularly toothed.  
 Covering only the base of rough ovoid ovary.  
 Style lateral, elongate.  
 Stigma Clavate  
 
FRUITS:  
 Fruits red when ripe.  
Figs sub globose or piriform borne in large clusters on short, leafless branches 
emerging from the trunk and the main branches.  
DISTRIBUTION:  
 6
 Throughout greater part of India from outer Himalayan range, Punjab, Bihar, 
Orissa and common in south India from sea level to about 1800m in evergreen forests 
and near streams in deciduous forests. 
 
Parts used.  
 Stem bark, root, leaf, fruit, latex, root bark 
 
Constituents 
 Tannin, wax and caoutehous and ash containing silica and phosphoric acid.  
 
Physical Constant: 37 
 Foreign matter   - not more than 2%  
 Total Ash    -  not more than 4%  
 Acid Soluble Extractive  - not more than 1%  
 Alcohol soluble Extractive -  not less than 7%  
 Water soluble extractive -  not less than 9% 
 
Analysis of the fruit gave the following values: 31  
 
 Moisture   - 13.6  
 Albuminoids  - 7.4 
 Fat   - 5.6 
 Carbohydrates  - 49.0 
 Colouring Matter  - 8.5 
 Fibre    -17.9 
 Ash    - 6.5 
 Silica    - 0.25 
 Phosphorus   - 0.91%  
Analysis of Leaves (air- dry basis)  
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 Nitrogen   - 0.915 
 Phosphorus   - 0.163 
 Lime (Cao)  - 5.57 
 
Analysis of Leaves (dry matter basis) 
 
 Crude Protein  - 12.36 
 Ether extract   - 2.75 
 Crude fiber   - 13.03 
 N – Free extr  - 58.88 
 Total Carbohydrates – 71.91 
 Total Ash   - 12.98 
 
BARK  
 Bark Contains 14% tannin  
 
CHEMICAL CONSTITUENTS:39 
Leaves, Bark and Heartwood  
 Tetracylic triterpene. Gluanol acetate characterized as 13 α, 14 β, 17 βH, 20 αH – 
Lanosta – 8, 22 – diene - 3β - acetates.  
 
Stem bark:  
 
 Two Leucoanthocyanins, Leucocyandin 3-0-β-D-Glucopyranoside 
Leucopelargonidin – 3-0- α – 2 L rhamnopyranoside.  
 Ceryl behenate  
 Lupeol – its acetate.  
 Stigma sterol  
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 α Amyrin Acetate  
 3 Un identified compound.  
 
BARK  
 Sitosterol  
 Unidentified long chain ketone.  
 
LEAVES 
 Glucoside  
 
FRUITS  
 Gluauanol, Lentrialcontane 
 β - sitosterol  
 Glauarol acetate  
 Tiglic  Acid ester of taraxasterol  
 Lupeol acetate  
 Higher Hydrocarbons and other phytosterol.  
 Glucose, Triedelin.  
 
ACTION: 38 
 Bark, Leaves and unripe fruit  
 
Hypoglycemic 
Astringent  
Carminative  
Stomachic  
Vermicide  
Hypotensive  
Cardiac- Depressant 
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Antiprotozoal   
Anti-inflammatory 
Hepato protective   
Anti diarrhoea  
 
Infusion of bark and leaves is astringent – Chopras I.D. of I PP.579. 
Bark is Cooling, Sweet and astringent Ayur Nighantum.  
 
USES : 30 
 
 Bark, Leaves and Unripe fruit are used externally and internally in dysentery.  
 Fruit is edible it is given on aphthous complains, menorrhagia, hemoptysis etc 
with sugar and honey.  
 Fruit and the sap extracted from trunk of the tree are efficacious in diabetes.  
 Powder of the seed mixed with honey 1/3 regarded specific in diabetes, reducing 
sugar in the urine, thirst and polyuria of diabetes.  
 In excessive of appetite it is advised by Sushruta to take the pulversied bark with 
milk.  
 The bark is used in the form of fine powder in dysentry, diabetes and menorrhagia. 
And in combination with gingelly oil it is applied to cancerous affections.  
 Infusion of the bark and the leaves is also employed as mouth wash in spongy gum 
and internally in dysentry menorrhagia and hemoptysis.  
 Young leaves crushed or reduced to powder or ripe figs mixed with honey are 
administered in bilious affections.  
 Juice of figs or cooled decoction is advised in cases of thirst.  
 
Fresh juice of the ripe fruit is given as adjunct or vehicle to a metallic medicine for 
diabetes and other urinary complaints.  
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 Fluid which yields on incision of the root is given alone or better mixed with 
cumin and sugar-candy in gonorrhea.  
 The sap of root gives relief in diabetes. And is usefully applied in cases of mumps 
and root juice is applied externally to other inflammatory glandular enlargements. 
 Root is used in pectoral complaints and dysentery.  
 A decoction of roots is recommended in menorrhagia.   
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EXPERIMENTAL STUDIES ON Ficus racemosa Linn 
 
MAPA, AUG 2007 
 
 Hypoglycemic properties of Ficus glomerata fruits in alloxan - induced diabetic 
rats - Journal of Natural Remedies. 
 
 Petroleum ether, benzene, chloroform, ethanol and aqueous extract of Ficus 
glomerata fruits was screened for hypoglycemic properties in alloxan – induced diabetic 
rats. The effect was assessed by blood glucose, serum cholesterol, serum urea and serum 
triglyceride levels. Oral dose of petroleum, ether extracts of 250mg/g body weight 
produced significant lowering of blood sugar, serum cholesterol, serum urea and serum 
triglyceride levels in alloxan induced diabetic treated rats. 
 
MAPA, JUNE 2002 VOL 24  
 
 Pancreas tonic an ideal herbal food supplement for diabetes mellitus. 
 
 Pancreas tonic is a dietary supplement composed of extracts of herbs namely 
gymnema Sylvestre (major component) Syzygium cumini, Trigonella foenum – graecum, 
Azadirachta indica , Ficus racemosa, Tinospora cordifolia Minerals and Vitamins at was 
given  to group of animals for 12 weeks  
 
 A significant improvement was found in pancreatic serum glucose levels by 
regenerating beta cells in pancreas islets. Similar response was identified in humans  
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MAPA, AUG 2004 VOL 26 
 
 A new anti inflammatory glycoside from Ficus racemosa Linn. 
 
 Bioassay guided fractionation of the ethanol extract of Ficus racemosa resulted in 
the identification of a new compound Racemosic acid. Racemosic acid showed potent 
inhibitory activity against cox-1 and 5- cox in vilro Racemosic acid also demonstrated a 
strong anti oxidant to scavenge ABTs free radical cations. 
 
MAPIS, JUNE 1986 
 
 The bark of Ficus spp – its beta sitosterol –D- glycoside is hypoglycemic38. 
 
DOCTOR NEWS:   JAN 1991. P.II38 
 
 Extract of bark reduce blood sugar by 62% due to presence of some carbohydrates 
and amino acids which are anti diabetic in nature. 
 
MAPA , FEBRUARY 1992. NOVEMBER 1642.38 
 
 Ficus racemosa bark reduces blood sugar in rats within a fortnight; effect in 
permanent. 
 
 Journal of national integrated medical Association 1991: 33(4): 8-12 
 
Anti diabetic effects of Gular-Alcoholic extract of it lowered blood sugar and 
cholesterol levels 
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REVIEW OF LITERATURE  
(GUNAPADAM ASPECT) 
 
ºkÆ ÿ√BÏ : 12  
  
 ∂›]–¶ º√Ï>ÁºB B§B¬ ºÔ”  
  ∂wÔV™ Bm\V°´ sÚ≠D  
 B›] ÿB[≈ ºB\>VÚ>Vƒ ÔV√È\VÚD  
  ºB›m\VD ]ÚEB\VD Ai∏BVzD  
 z›]ÿB[≈ B›]BVK¬ÔV zuÆÈÔÈ\V∫  
  Ì§B cAi√D √ÈkVzﬁ 
 E›]ÿB[≈ ÔΩsÚﬂE √ﬁƒÔ›] ÿkV[≈Vﬁ  
  ÿƒ©∏Bº>V ´›]•¶ﬂ ÿƒBK\Vº\  
     á º√VÔÏ WÔı| (√.269)  
 
º\>VÚ, Bm\V≠V sÚ≠D, >VƒÔV√ÈD, ]ÚﬂEBDAi∏, ∂Ai√©√ÈV,  
sÚﬂE, √ﬁƒ›] g˛BÁk ∂›]l[ ÿ√BÏÔ·VzD.  
 ∂>D, ∂>°, cmD√´D, ºÔVπ, ∑©∏´>i¶D g˛BÁk ∂›]l[                 ºkÆÿ
√BÏÔ^. 1 
 
÷m \´kz©Á√ ºƒÏÕ>m. ÷Õ]BVs_ ®∫zD √l´V˛≈m.  
 
√B[√|D cÆ©A : 1 
 ∏ﬁ∑, ÔVF, √wD, √V_, √‚Á¶, \m  
 
∏ﬁ∑  
 ∑Ák  - mkÏ©A, >[Á\  á >‚√D, ∏ˆ° á ÷M©A  
ÿƒFÁÔ :  mkÏ©∏ á   Astringent 
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zD :
  mkÏ©AÁ¶B ∂›]©∏ﬁ∑ JÈkV• JÈ¬˛´VË, ÷´›>JÈD, kluÆ 
 Ô|©A g˛B ÷ÁkÔÁ·© º√V¬zD  
 
ÔVF :  
 
 ∑Ák á mkÏ©A, >[Á\ á >‚√D, ∏ˆ° á ÷M©A  
ÿƒFÁÔ :  mkÏ©∏ á   Astringent  
zD : 
 ÿk^Á·, kV>ºÂVF, ÛÁÈ, c¶_ÿk©A, Aı (s´D) g˛B  
÷ÁkÔ^ º√VD.  
 ""∂›]¬ÔVF >[Á™ ∂ÚÕ]™V_ g´∫ºÔ  
   ®›]¬zD º\ÔD ÷Ú©√mıº¶V? á ƒ›]¬zD  
   kV>D ∂ÔKD \È∫Ôa•D ÛÁÈÿBV|  
   *>™KD AıbD º√VD s^''' 
 
√wD :  
 
 ∑Ák á ÷M©A, >[Á\ á >‚√D, ∏ˆ° á ÷M©A  
ÿƒFÁÔ :  
  zÚ] ÿ√Ú¬˛  á   Improves blood  
  \Èt·¬˛  á   Laxative  
zD :  
 ∏›> ºÔV√D, ¿ˆa°, ÛÁÈ, ÷´›> J›]´¬˛ˆﬂƒ´D g˛B ÷ÁkÔÁ·©  
º√V¬zD.  
 ¿ˆas_ ∏≈Õ> ∏·Ák, ˇ_kV>D, J‚| T¬ÔD ÷ÁkÔ”¬z ÷©√VÁÈ  
√u§‚| k´, ÂV”¬zÂV^ Â[Á\ >ÚD.  
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√‚Á¶ :  
 ∑Ák á mkÏ©A, >[Á\ á >‚√D , ∏ˆ° á ÷M©A  
 
ÿƒFÁÔ :  
  mkÏ©∏ á   Astringent 
 
zD  
  TÆ Ô|©∏´›>D ÿkıÊ> ´›>ÿ\V|  
  ÂVÆs´ ∫Ôÿ·ÈVD ÂV¶VkVD á ÌÆ∫ÔV_  
  ∂›] >Ú º\ÔD º√VD glÁwºB! ®ﬁQV[ÆD  
  ∂›]©√Vu √‚Á¶¬ Ô§  
 
ÿk^Á·, º\ÔD, ˇµkVFÔ|©A, zÚ]©º√V¬z, Ê>¬Ôaﬂƒ_,  
ÂVu≈x^· AıÔ^  g˛BÁkÔÁ·© º√V¬zD.  
 
kw¬zÔ^ : 17 
 
∂›]©√‚Á¶ ŒÚ ∏Ω, ∂ˆÿÂ_o¬ÔVF 1 √Ω, kVÁw©√wD á 4 ÷ÁkÔÁ· ÷Ω›m ´
ƒD∏aÕm ∂]_ Ê™V¬ÔuÔı| º√V‚| ÿÔV|¬Ô ∏›> Œ¬ÔV·D c¶º™  
WkÏ›]BVzD.  
 
 ∂›]©√‚Á¶, gkV´D√‚Á¶, ÂVk_√‚Á¶, ÷ÁkÔÁ· ƒ\ÿ™Á¶ÿB|›m Û´Ë›
m   º>MoÁw›m   ÷ÚºkÁ·•D 5 (∂) 10   ÂV^   cı  Êµ∏´tBD  
WkÏ›]BVzD.  
 
 ∂›]©√‚Á¶ÁB¬ ˛BVÔwD Ák›m  ÷ÚºkÁ· ƒV©∏‚¶V_ J›]´›º>V| ÷´›>D
 kÚ˛≈ sBV] WkÏ›]BVzD.  
 
 ∂›]©√‚Á¶,   \VD√‚Á¶,   ÂVk_ √‚Á¶   ƒ\ÿ™Á¶    Aπ©A >lˆ_ ŒÚ    ÂVj
§B ∏[ ÷Ω›m ƒVÆ∏aÕm ∂]ÔVÁÈl_ ƒV©∏¶ ÿk^Á· ¿∫zD.  
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1. ¿ˆasuz ∂›]©√‚Á¶ Ô≠VBD 20   
 
∂›]\´©√‚Á¶    Â[™VˆºkÏ  
gkV´D √‚Á¶   Ô¶o´ﬁE √‚Á¶  
\Ú>D √‚Á¶    ÷K©Á√√‚Á¶  
¿ÏØÈV ºkÏ    ÿÔV[Á≈√‚Á¶  
AπBD√‚Á¶    EÆˇÁ´ºkÏ  
ÊÕ]_ ÿÔVΩ     ºÔVÁ´˛w∫z  
Â›Á>Ûˆ ºkÏ   Ôu≈VÁw  
ÂV´›Á> ºkÏ  
 
÷ÁkÔÁ· Ô_K´oo‚| Â[≈VÔ ÷Ω›m Js´_ ÿÔV^”\·ÿk|›m ŒÚ  
√V›]´›]o‚| ∑›> ¤ÈD E[™©√Ω 1/2 s‚| ∂|©∏[º\ºÈ ®‚|ÿÈV[≈VzD   √Ω ®ˆ›
m c‚ÿÔV^·°D.  
á 20 ÂV‚Ô^  
á ¿ˆa° yÚD  
 
2. º\Ô¿ˆasuz \ÚÕm 16    
  
∂›]  
Ô¶ÈaﬁE_  
Øk´∑  
\ﬁƒ›]  
{]  
ÿk^ºk_  
ÔÚºk_  
gkVÁ´  
ÿƒ∫˛”Ák  
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÷ÁkÔπ[ √‚Á¶ kÁÔ¬z á 10 √ÈD 8 ÂV^ ª≈Ák›m 1 √ΩBVF ku≈Ák›m  
∏[,  
ÔVÕ>D  
∂©∏´Ô ÿƒÕ#´D  
E‚¶D  
∂´©ÿ√VΩ  
º>u≈V[ sÁ>  
Ô|¬ÔVF  
s·VD∏E[  
ÔVZBD  
÷´ƒD  
 
cÚ¬˛ ÿ√VΩ›> ÿ√VΩ, ºkÈD∏E[ ÷ÁkÔÁ· Ô_k›]_ ÷‚| º\u√Ω¬   zΩ¿ˆ
_   g‚Ω   10   k´VÔ[   ®Á¶•^·   cÚıÁ¶ÔÁ·¬  ÿƒFm  ÿÔVı|  
c‚ÿÔV^·°D  
 
∂·° : 1 cÚıÁ¶  
∂–√V™D á gkVÁ´ ∂ˆE á º>[  
 
3. º\Ô›]uz \ÚÕm 16 
 
∂›], \Úm ÷ÁkÔπ[ √‚Á¶l™V_ ÔÚk∫Ô›Á> ˛ıΩ kÆ›m 
ÿ√VΩBV™][ º√ˆ_ ∂>uzﬂ ƒ\[ Û>D s‚| √‚Á¶BV_ ƒuÆ ºÂ´D ˛ıΩ  
√ÈD WÆ›m Ô_k›]o‚| ]ˆ√ÁÈ, gkVÁ´, Ô¶ÈaﬁE© √‚Á¶ kÁÔ¬z 1 √ÈD Ì‚Ω© 
ÿ√VΩ›m Â_ÿÈıÿl_ ª≈Ák›m¬ÿÔVı| º\u√Ω ®ıÿl_  
ÔÈÕm ºkÁ·¬z c‚ÿÔV^·°D.  
∂·° : ºkÁ·¬z 1 cÚıÁ¶  
yÚD ºÂVF : º\ÔD yÚD.  
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4. º\Ô´V¤V∫Ô ˛Ú>D:6  
∂›]©√‚Á¶, ÂVku√‚Á¶, Œ]BD√‚Á¶, kÁÔ¬z 1/4 TÁƒ ÂÆ¬˛ ÷Ω›m  
6 √Ω ¤ÈD s‚| 3/4 √ΩBVÔ ÔVFﬂE ∂]_,  
 
ÔÚDA´ƒD  
ÿÂ_o¬ÔVF ƒVÆ  
®KtﬂÁƒ ´ƒD, ®^ÿ·ıÿF  
√∑s[ ÿÂF á 1/2 √Ω  
 
>Vπƒ√›]ˆ, ∞ÈD, ˛´VDA,  ¤V]¬ÔVF, Eu≈´›Á>, ∂]\m´D, WÈ©√Á™  
˛w∫z Û´D kÁÔ¬z 3/9 √ÈD  ÷ÁkÔÁ· º>∫ÔVF √VoÈÁ´›m x[ 
zΩ¿ˆ_ ÔÈÕm ÔVFﬂE kΩ›m ÿÔV^Ô.  
 
∏´ºBVÔD : ÔVÁÈ, \VÁÈ 
           1 Ô´ıΩ  
            9 ÂV^  
yÚD ºÂVF :  ¿Ï∑Ú¬z. ÿk^Á·. ƒÁ>BÁ¶©A, ÿ√ÚD√V|, ®KDAÚ¬˛, √Vı| 
 z©√|D.  
 
5. ∂©∏´Ô ÿƒÕ#´D19  
 
 ∂©∏´Ô›Á> ºkıΩB ∂·° ®|›]Ω›m ∂›]ºkÏ√‚Á¶, gÈD√‚Á¶,  
∂´ƒD√‚Á¶ ÷ÁkÔÁ· ÷Ω›m ¿Ïs‚| ª≈Ák›m g‚Ω, ®Ú¬˛ÁÈl_  
∂Á¶>‚Ω ®Ú Ì‚Ω© A¶D º√V¶°D. 21 xÁ≈ ÿƒFB ÿƒÕ#´\VzD.  
∂·° : √ÿkÁ¶  
mÁ \ÚÕm : º>[  
yÚD ºÂVFÔ^ : ¿ˆa°, ˛ˆﬂƒ´D, z[\D  
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∏≈ \ÚÕmÔ^ :  
1. ∏›>›>VKı¶V™ º>Ô ®ˆﬂƒK¬z¬ ˛BVwD47  
∏´ºBVÔD  á ºkÁ·¬z 2 ∂°[¸.  
yÚD sBV] á ∏›>›>VKı¶V™ º>Ô ®ˆﬂƒ_  
  ∏›>›>VÿÈøÕ> >øDA z\VzD.  
 
2. ÿk^Á· ∂√©∏´Ô ÿƒÕ#´D47  
∏´ºBVÔD á ºkÁ·¬z z[§ÿBÁ¶  
           ]™D 2 ºkÁ·  
yÚD ºÂVF á º\ÔD 21, rBD, ˛´VË  
 
3. gkVÁ´ ÿÂF 6 
 ∂·° : 1 Ô´ıΩ, ]™D 1(∂) 2 ºkÁ·, 1 \ı¶ÈD  
 yÚD ºÂVF : ∏´º\Ô∫Ô^, ƒÔÈ º\Ôº´VÔ∫Ô^, ¿ˆa°, J›]´˛ˆﬂƒ´D  
 
4. º\Ô´VƒV∫Ô ºÈ˛BD18  
ÂV··°      : 1 \ı¶ÈD  
yÚD ºÂVF : kV> ∏›>, EºÈ›m\›>V_ ®øÕ> ºÂVFÔ^,  20 º\Ô ºÂVF,  
÷Á·©A, ~Á· yÚD.  
 
5. >V√∑´¬ Ô≠VBD6    
∏´ºBVÔD   : 2 ºkÁ· á 3 ÂV^  
yÚD ºÂVF : ∂]ƒV´D, >V√∑´D                                        
 
6. kÎ˜´Ô√V¶ ÷ºÈ˛BD 6 
∏´ºBVÔD  : ]™D 2 ºkÁ·  
    ÔwuE¬ÔVF ∏´\VD,  20 ÂV^  
yÚD ºÂVF : JÈD, JÈ¬˛´VË, ciº√].  
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7. ÷´ƒÿÔÕ] ´VƒV∫Ô ÿ\øz6  
∂·°          : ∑ıÁ¶¬ÔVB·°, 1 \ı¶ÈD  
yÚD ºÂVF : ∂Á´BV©A, ÿk^Á· , ÿkΩÛÁÈ, \mº\ÔD yÚD.  
   
 
PHYSIO CHEMICAL STANDARDISATION OF Ficus racemosa 
 
Physical Constants 39 
 
Foreign Matter  - Not More than 2%  
Total Ash   - Not more than 4%  
Acid Soluble Extractive  - Not more than 1%  
Alcohol Soluble Extractive - Not less than 7%  
Water soluble Extractive  - Not less than 9%  
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METHODOLOGY  FOR PHARMACOGNOSY STUDY  
ATTI (ROOT BARK) 
 
MATERIALS AND METHODS  
 
 The root bark of Ficus racemosa Linn. (Fam. Moraceae) was collected form 
Pollachi, Coimbatore District. They were fixed in FAA (Formalin 5ml and Acetic acid 
5ml and 70% ethyl alcohol 90 ml) in the field itself. Hand sections were taken, stained 
with safranin. Glycerine mounted temporary preparations were prepared. Microtome 
sections were taken, stained and mounted according to standard procedure. For paraffin 
embedded sectioning the usual procedure of hydration and clearing was followed by 
employing ethyl alcohol (Johansen, 1940). Photomicrographs of different magnifications 
were taken with Nikon Eclipse E200 microscopic unit.  
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RESULT FOR PHARMACOGNOSY STUDY OF ATTIVER PATTAI 
(Ficus racemosa) 
 
MACROSCOPIC:  
 
 The  outer surface is fairly smooth and not deeply cracked or fissured, pale brown 
in colour; inner surface brown red; no characteristic odour and taste.  
 
MICROSCOPE:  
 
 The cork tissue or phloem is composed of 7 or lesser number of rows of slightly 
thick walled rectangular cells. (Fig II A). A distinct phelloge of one or two rows of 
narrow rectangular cells are present and beneath this is a phelloderm composed of 6 to 10 
or more rows of regularly arranged thin – walled rectangular cells, which contain starch 
grain and rhomboidal crystals. The cortex is a fairly wide zone, the cortical parenchyma 
cells are spherical –oblong, thin – walled and most of the cells contain tannin. Some cells 
are packed with starch grains and others contain rhomboidal crystals of Calcium oxalate. 
Sparsely scattered in the cortex are irregular groups of stone cells (Fig. II B, D & E).  
 
The medullary rays are 2 to 5 seriate and their distal ends are very wide, with large 
and tangentially elongated cells (fig. II C F). These distal ends almost extend to the 
periphery of the cortex. The inner bark or bast forms the widest part of the bark. It is 
composed of alternating radial segments of phloem and medullary rays.  
 
The bast is somewhat densely scattered, with small groups of sclerenchyma.. 
These cells are large, thick walled and occurs as single or  few celled groups. Some of the 
phloem parenchyma cells contain rhomboidal crystals of Calcium oxalate. Phloem 
consist of sieve tubes, companion cells and phloem parenchyma. Most of the cortical 
parenchyma and phloem parenchyma cells contain tannin (fig II D, E).  
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POWDER :  
 Reddish Brown; shows cork cells, tanniniferous cells, stone cells and 
parenchyma cells.  
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PREPARATION OF THE DRUG  
ATTIVERPATTAI CHOORNAM 
 
COLLECTION OF THE DRUG 
 
 The root bark of Atti was collected at a forest area near Pollachi.  
 
PURIFICATION AND STORAGE  
 
 The root bark was washed in fresh water and cleaned thoroughly and was allowed 
to dry in shade and stored in moisture proof containers and powdered. 
 
PREPARATION OF CHOORNAM 
 
 The drug Attiverpattai Choornam was taken from the literature 
 “ Vaidhiya Perungural”.  
 
 The dried root bark was made into fine powder and sieved through a white cloth 
(Vasthira kayam). Then it was purified by steam- cooking in milk (pittavial method). The 
same was later powdered and sieved again and preserved. 
 
STORAGE OF CHOORNAM 
 
 The choornam was stored in clean air tight container 
 
ADMINISTRATION OF THE DRUG 
 
Form of 
Administration 
Route Dose 
Time of 
Administration 
Vehicle 
Choornam Enteral 1gm, 2 times a day Before Food 
Water about 
30ml 
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METHODOLOGY FOR IDENTIFICATION OF PLANT 
ATTIVERPATTAI CONSTITUENTS BY  
PHYTO CHEMICAL TESTS  
 
 The drug powder and various extracts of Atti Verpattai Choornam were 
subjected to chemical tests for identification of its active constituents. 
 
TEST FOR ALKALOIDS: 
 
 A small portion of the solvent, free chloroform, alcoholic and aqueous extracts 
were treated separately with few drops of dilute HCL and filtered.  The filter may be 
tested carefully with alkaloidal reagents such as, 
  a. Mayer’s  reagent  – yellow precipitate 
  b. Dragendroff’s reagent  – Orange brown precipitate 
  c. Wager’s reagent   -  Reddish brown precipitate 
 
TEST FOR CARBOHYDRATES 
Molisch’s test: 
 
 Filterate was treated with 2-3 drops of 1 % alcoholic alpha – napthol solution and 
2 ml of concentrated H2SO4 was added along the sides of the test tube.  Appearance of 
brown ring at the junction of 2 liquids show the presence of carbohydrates. 
 
TEST FOR GLYCOSIDES. 
 
 Another portion of Attiver Pattai Choornam was hydrolysed with HCL for few 
hours on a water bath and the hydrolysate was subjected to Legal’s Bentrager’s test to 
detect the presence of glycosides  
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A.  LEGAL’S TEST 
 
To the hydrosylate, 1 ml of pyridine and few drops of sodium nitro prusside 
solution were added and then it was made alkaline with sodium hydroxide solution.  
Appearance of pink to red colour shows the presence of glycosides and aglycones. 
 
B. TEST FOR PHYTOSTEROL 
 LIEBERMAN BURCHARD TEST. 
 
 1 gm of the extract of Attiver Pattai Choornam was dissolved in few drops of 
dry acetic acid 3 ml of acetic anhydride was added followed by few drops of concentrated 
sulphuric acid.  Appearance of bluish green colour shows the presence of phytosterol. 
 
TEST FOR SAPONINS. 
 
 The extracts of Attiver Pattai Choornam was diluted with  20 ml of distilled 
water and it was agitated on a graduated cylinder for 15 minutes.  The formation of 1 cm 
layer of foam shows the presence of saponins. 
 
TEST FOR TANNINS AND PHENOLIC COMPOUNDS. 
 
 Small quantities of various extracts were taken separately in water and tested for 
the presence of phenolic compounds and tannins by adding dilute ferric chloride solution 
(5%).  The formation of violet colour shows the presence. 
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TEST FOR PROTEINS AND FREE AMINO ACIDS 
 
 Small quantities of various extracts of ATTHIVER PATTAI were dissolved in a 
few ml of water and treated with ninhydrin reagent.  Appearance of purple colour shows 
the presence of proteins and free amino acids. 
 
TEST FOR FLAVANOIDS. 
 
 With aqueous sodium hydroxide solution the extract gives blue to violet colour if 
anthocyanins are present, yellow colour if flavones are present yellow, to orange if 
flavones are present. 
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RESULTS OF PHYTOCHEMICAL TESTS OF ATTIVERPATTAI 
CHOORNAM(Ficus racemosa) 
 
 
Sl.No Constituents Attiverpattai Choornam
1. Alkaloids - 
2. Carbohydrates - 
3. Glycosides + 
4. Saponins + 
5. Tannins + 
6. Amino acids + 
7. Flavanoids + 
8. Phenol + 
9. Phytosterol + 
10. Protein + 
11. Tannic Acid + 
 
 
INFERENCE:  
 The Phytochemical tests of Attiverpattai Choornam showed the presence of 
Glycosides, Saponins, Tannins, Amino acids, Flavonoides, Phenol, Phytosterol, Protein 
and Tannic acid.  
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METHODOLOGY FOR THIN LAYER CHROMATOGRAPHY OF 
ATTIVER PATTAI (Ficus racemosa)  
 
METHOD:  
 
 2g of the sample was soaked in 20ml of rectified spirit (90%) for 18 hrs and 
boiled for 10 minutes and filtered. The filtrate was concentrated and made upto 
10ml. 5µl of  alcoholic extract was applied on Merck Aluminium plate pre-coated 
with Silica gel 60F254 of 0.2 mm thickness along with the ingredients using 
Linomat IV applicator. The plate was developed in Toluene; ethyl acetate; formic 
acid 5:2.5:0.5 v/v. The plate was visualized in UV 254 and 366nm. In 366nm no 
visible spots are found The plate was then dipped in Vanillin –Sulphuric acid and 
heated in air oven at 105ºC till the spots appeared.  
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RESULT FOR THIN LAYER CHROMATOGRAPHY OF ATTIVER 
PATTAI (Ficus racemosa)  
 
S.No 
UV 254 nm With Spray reagent 
Colour  Rf Colour  Rf 
1. Pale Green  0.11 - - 
2. Green  0.24 - - 
3. Pale Green 0.38 - - 
4. Pale Green 0.51 - - 
5. - - Dark Grey 0.81 
6. - - Dark Grey 0.92 
7. - - Dark Grey 0.97 
 
 
 
INFERENCE :  
 
 The alcoholic extract of Attiverpattai Choornam under UV 254nm showed the 
Rf values 0.11,0.24,0.38,0.51 and with spray reagent it showed the Rf values 0.81, 0.92, 
0.97. 
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METHODOLOGY FOR ANTI-MICROBIAL STUDY 
 
METHOD: 
 
 The anti-bacterial activities of different extracts of Atthiver Pattai choornam 
were studied by disc diffusion method against the following organisms. 
 
1. Streptococcus mutans 
2. Staphylococcus aurens 
3. Escherichia coli 
4. Klebsiella preumoniae 
5. Pseudomonas aereginosa 
6. Candida albicans  
 
Extracts of Atthiver Pattai were used in the concentration of 100, 50 and 25 ml 
using their respective solvents.  Ciprofloxacin ( 50 mcg / disc ) was used as standard. The 
disc diffusion method was employed for the screening of anti – bacterial activity. 
 
DISC DIFFUSION METHOD. 
 
 A suspension of organism was added to sterile soya bean casein digest agar media 
at 45oC, the mixture was transferred to sterile petridishes and were allowed to solidity. 
Sterile discs, 5 mm in diameter, dipped in solutions of different extracts, standard and a 
blank was placed on the surface of agar plates.  The plates were left standing for one hour 
at room temperature as a period of pre incubation diffusion to minimize the effects of 
variation in time between the application of the different solutions.  Then the plates were 
incubated at 37o C for 18 hours and observed for anti-bacterial activity.  The diameter of 
zones of inhibition were observed and measured.  The average area of zones of inhibition 
were calculated and compared with that of standard’s. 
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RESULT FOR ANTI MICROBIAL STUDY OF ATTIVERPATTAI 
CHOORANAM  
 
Organism 
Standard 
drug 
Ciprofloxacin 
50 mcg/disc 
Test drug (APC µl/disc ) 
Zone of Inhibition in mm 
100µl 25µl 50µl 
Ster. mutans  31 18 21 23 
Stap. Aureus 30 16 20 24 
E. Coli 29 15 19 22 
Klebsiella 
pneumoniae 
30 19 23 25 
Pseudomonas 
Aeruginosa 
31 15 18 21 
 
14 mm – Low sensitive, 15mm – Moderate, above 16mm – highly sensitive  
 
NOTE :  
SAMPLE CONCENTRATION : -  
  4gm – 400 ml of solvent in 25µl, 50µl, and 100µl/disc  
 
Standard for Bacteria :  
  Ciprofloxacin HCL, 50 mcg/ disc 
 
Standard used for fungus :  
  4.0 gm – 400 ml of solvent, 10µl, 25µl, 50µl/disc  
 
 
INFERENCE:  
 
 The Antimicrobial study of Attiverpattai Choornam shows that it is highly 
sensitive against Strp. mutans, Stap. aureus, E.coli, Klebsiella and Pseudomonas.  
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METHODOLOGY FOR BIO – CHEMICAL ANALYSIS. 
 
PREPARATIONS OF EXTRACT 
 
 5gm of Attiver Pattai Choornam was weighed accurately and placed in a 250 ml 
clean baker and added with 50ml of distilled water. Then it was boiled well for about 10 
mins. Then it was cooled and filtered in a 100ml volumetric flask and made upto 100ml 
with distilled water. 
 
TEST FOR CALCIUM. 
 
 2ml of extract was taken in a clean test tube. To this 2ml of 4% ammonium 
hydroxide solution was added.  Presence of calcium is denoted by formation of a white 
precipitate. 
 
TEST OF IRON (FERRIC) 
 
 The extract was treated with glacial acetic acid and potassium Ferro cyanide. 
Presence of ferric Iron is denoted by a blue colour  
 
TEST FOR IRON (FERROUS) 
 
 The extract was treated with conc. HNO3 and ammonium thiocyanate. (presence of 
ferrous iron is denoted by formation of blood red colour) 
 
TEST FOR SULPHATE: 
 
 2ml of the extract was added to 5% barium chloride solution. Presence of sulphate 
is denoted by formation of a white precipitate. 
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TEST FOR CHLORIDE: 
 
 The extract was treated with silver nitrate solution. The presence of chloride is 
denoted by formation of a white precipitate. 
 
TEST FOR CARBONATE: 
 
 The extract was treated with concentrated HCL. If carbonate is present, it is 
denoted by effervescence. 
 
TEST FOR PHOSPHATE: 
 
 The extract was treated with ammonium molybdate and conc. HNO3 if phosphate 
is present, it is denoted by the formation of a yellow precipitate. 
 
TEST FOR UNSATURATION: 
 
 1ml of potassium permanganate solution is added to the extract. The presence of 
unsaturation is denoted by decolourisatrion. 
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RESULTS OF BIO – CHEMICAL ANALYSIS 
 
Sl.No Constituents Attiverpattai Choornam
1. Calcium  + 
2. Iron  (Ferric)  - 
3. Iron (Ferrous)  + 
4. Sulphate  - 
5. Chloride  + 
6. Carbonate  - 
7. Phosphate  + 
8. Unsaturated  - 
 
The acid radicals present were Chloride and Phosphate  
The Basic radicals Present were Calcium and Iron (ferrous)  
 
 
RESULT OF QUANTITATIVE ANALYSIS  
 
Sl.No Test Parameters Result 
1 Zinc as Zn 37.8mg/kg  
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PHARMACOLOGICAL STUDY OF  
ATTIVER PATTAI CHOORNAM (Ficus racemosa) 
 
MATERIALS AND METHODS 
Test Drugs 
 
 The following medicinal plants were used in the study were collected and 
processed by the methods prescribed in standard text books of siddha medicines. 
 
     Attiverpattai Choornam  was prepared by the method described in (Vaithiya 
Perungural, pg.no 49) 
 
Preparation of drug for dosing 
 
 Attiverpattai Choornam  used for the study was suspended each time with 1% 
(w/v) solution of sodium carboxy methyl cellulose before administration. 
 
Drugs and chemicals 
 
 Alloxan monohydrate and fine chemicals used in these experiments were obtained 
from Sigma Chemicals company, U.S.A. Other analytical grade chemicals were obtained 
from S.d. Fine Chemicals Ltd., Mumbai. 
 
Experimental animals  
 
 Colony inbred animals strains of wistar rats of either sex weighing 200 - 250 g 
were used for the pharmacological and swiss albino mice of single sex were used for 
toxicological studies. The animals were kept under standard conditions 12:12 (day/night 
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cycles) at 220C room temperature, in polypropylene cages. The animals were fed on 
standard pelleted diet (Hindustan Lever Pvt Ltd., Bangalore) and tap water ad libitum. 
The animals were housed for one week in polypropylene cages prior to the experiments 
to acclimatize to laboratory conditions. The experimental protocol was approved by the 
Institutional Animal Ethical Committee (IAEC). 
METHODOLOGY FOR ACUTE ORAL TOXICITY STUDY 
 
Acute oral toxicity was conducted as per the OECD guidelines (Organization of 
Economic Cooperation and Development) 423 (Acute Toxic Class Method). The acute 
toxic class method is a stepwise procedure with 3 animals of a single sex per step. 
Depending on the mortality and /or moribund status of the animals, on the average 2-4 
steps may be necessary to allow judgment on the acute toxicity of the test substance. This 
procedure results in the use of a minimal number of animals while allowing for 
acceptable data based scientific conclusion. 
 
The method uses defined doses (5, 50, 300, 2000 mg/kg body weight) and the 
results allow a substance to be ranked and classified according to the Globally 
Harmonized System (GHS) for the classification of chemicals which cause acute toxicity 
 
EXPERIMENTAL PROCEDURE  
 
 Swiss albino mice of either sex weighing. 20- 25g were used for the study. The 
starting dose level of Attiverpattai choornam was 2000 mg/kg body weight (per oral). 
As most of the crude extracts posses LD 50 Value more than 2000 mg/kg P.O, the 
starting dose used was 2000 mg/kg P.O. Dose volume was administered 0.1ml/10 gm 
body weight to the mice which were fasted over night. With water ad libitum Food was 
withheld for a further 3 to 4 hours after administration and observed for signs of toxicity. 
Body weight of the mice before and after administration, were noted and any changes in 
skin and fur, eyes and mucous membranes and also respiratory, circulatory,. Autonomic,  
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central nervous systems, somatomotor activity  and behavior pattern were observed, and 
also signs of tremors, convulsion, salivation, diarrhoea, lethargy, sleep and coma were 
noted. The onset of toxicity and signs of toxicity were also noted.  
 
 
  
RESULTS FOR ACUTE ORAL TOXICITY STUDY 
 
 
Attiverpattai Choornam at the dose of 2000mg/kg/po did not exhibit any 
mortality in mice. As per OECD 423 guidelines the dose is said to be “Unclassified” 
under the toxicity scale. Hence further study with higher doses was not executed.  
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METHODOLOGY FOR ANTI DIABETIC ACTIVITY OF 
ATTIVERPATTAI CHOORNAM 
 
1. Alloxan induced diabetes in wistar rats   
 Test Drug  :  Attiverpattai Choornam  
 Animals  : Male wistar albino rats (300-350 g) 
 Drugs  : Alloxan monohydrate (150 mg/kg/s.c) Sigma  
USA, Glibenclimide (5 mg/ kg, i.p) US Vitamins, India 
Induction protocol  
 
1. Animals (n=18) were randomly selected, numbered and weighed.  
 
2. Alloxan monohydrate (150 mg/kg/s.c) was injected to all animals and observed for 
48 hours. To avoid hypoglycemic convulsions and death rats were injected with 
5% glucose i.p and maintained on drinking water contains 5% glucose for 48 hrs.  
 
3. After 48 hours the blood glucose level was determined using glucometer. 
 
4. Animals showing blood glucose level ≤ 300 mg/dl were taken for the study. 
 
5. Animals showing hyperglycemic ≤ 300 mg/dl were distributed to various groups. 
 
6. Test drug/standard drugs were given for 6 days. 
 
7. At the end of 6 days, animals were fasted to 10 hrs and the fasting blood sugar was 
estimated by glucometer and reported as mg/dl.  
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RESULTS FOR ANTI DIABETIC STUDIES 
 
 
Attiverpattai Choornam exhibited significant antidiabetic activity in alloxan 
induced diabetes in rats. The results obtained from the study establish its efficacy with 
good correlation with clinical study findings reported in the thesis. 
 
Effect of Attiverpattai Choornam  
on Blood Glucose level in rats 
 
 
Groups Blood Glucose concentration (mg/dl) 
Control 139.667 ± 15.187 
Standard 80.166 ± 5.606*** 
Attiverpattai Choornam 
(500mg/kg. p.o.,) 
68.32 ± 6.88*** 
 
N=6; Values are expressed as mean ±S.D followed by Students Paired ‘t’ Test 
***P<0.001 as compared with that of control is considered as significant. 
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CLINICAL ASSESSMENT 
MADHUMEGAM 
 
SIDDHA ASPECT 
 
 In Siddha system of medicine the ‘Neer noikal’ have been classified broadly under 
2 main categories as Neer perukkal noi, Neer arukkal noi 
 
""  ¿ˆÚsÁ™¬ z›Á> ¿B§ sˆ›mﬂ ÿƒV_kVD  
¿ˆÁ™© ÿ√Ú¬Ô ÿÈV[Æ ¿ˆÁ™BÚ¬Ô ÿÈV[Æ  
¿ˆa°¶º™ ÿÔV_KD ¿Ï¬Ô‚| sÁ™Ôÿ·V[Æ  
¿ËB xÁ´¬ztÕ> ¿ÏWÁ≈¬ z›Á>¬ ºÔ·VF  
                  á º>Á´BÏ \ÔV Ôˆƒ_  
 Among the Neernoikal, Madhumegam is described under neer perukkal noi. 
 
VERUPEYARGAL (synonyms) 
   Neerhizhivu, Inippu neer. 
 
Iyal (Definition)22 
 
 Madhumegam is defined as a disease in which there is large quantity and  high 
frequency of micturition, derangement of 7 udal thathukkal and loss of weight. 
 
""  ¿ˆÁ™ ÿ√Ú¬ÔÿÈ[–D ¿ˆasÈ¬Ô∫ºÔ^ 
   ¿ƒ kVˆ] º√VuÚ¬˛ ¿‚Ω¬zD xÁ≈ >^·V|D 
   ¿s Ì¶Vm ÁÔÔV_ ¿È \VsÁ™ ºÂ´VzD 
   ¿ﬁ ÿƒVV ∂´Ë[ Jﬂ∑ ¿ƒ\V xB¬zD ÔV‚|D "" 
Noi varum vazhi (aetiology): 
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 According to yugi vaidhya chindamani, the etiology of madhumegam is explained 
as follows: 
 
"" cu√s¬zD √V_ ÿÂFBV_ ÷Á≈ﬂE Ô^·V_ 
  cˆÁƒBVD *[≈[™V ÈÚs›> 
  \u√s¬zD √>VÏ>›>V_ \m´ k¸>V_ 
  \Õ>∫Ô^ >Á™ÿ√VE›>_ ºkÔV©√ı¶∫ 
  zu√s¬z∫ z”Õ> √[™ \∫ÁÔ ºÔViΩ 
  z§›> W›]Á´ >sÏ >È¬˛M \Õ>D 
  >u√s¬zDﬁ ƒZ´Õ>V™ tÔ© √Ú›>u 
ƒﬁƒÈÕ>V™ tÔ© √B›>V_ >ˆ¬ÔD ºÂVºB"" 
 
In Agasthiyar 2000,  
 
ºÔVÁ>BÏ ÔÈs º√VÁ> 
ÿÔVø›> *MÁ≈ﬂE º√VÁ> 
√VmkVF ÿÂF•D √VKD 
√ˆ°¶–¶[ cı¨´V˛_ 
ºƒV> √Vı| Úk t¬Ô 
∑¬˛È ∏´º\ÔÕ>V[ 
{m ¿ˆa° ºƒ´ 
°ıÿ¶™k§Õm ÿÔV^º·"" 
                                            ∂Ô›]BÏ 1200 
  
Excessive intake of fat and high caloric foods such as milk, ghee and meat, increased 
intake of alcoholic beverages, excessive carbohydrate intake, eating indigestible and cold 
food, disturbance in sleeping, excessive involvement in sexual activities, obesity stress 
and fear are mentioned as the etiological factors for Madhumegam. 
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KURIGUNAM (CLINICAL FEATURES): 
 
"" >VÔº\ B]Ô\V˛› >·ÏÕm ÂV cÈÏÕm t¬Ô 
  ºƒVÔ\VF¬ ˛Æ˛Æ›m› ÿ>V¶ÏÕm ÁÔÔVKD ºƒVÏÕm 
  ®Ô\VF© √ÔKD ∂_KD s¶Vm ¿ˆ≈∫zD ∂[§ 
  º\Ô\VF \Áw √π¬z xÏÕ]≈∫˛|ﬁƒÈÕ>V[ 
       Ák›]B s·¬ÔD 
 
Poly dipsia, dryness of tongue, fatigue, giddiness, general weakness, polyuria are 
some of the clinical features. 
 
mkÏ©A44 
"" Ô‚|km ƒuÆ Ô´Ô´©√V¬zkm 
  ]‚¶\VF› º>Vu√>™ﬁ ÿƒFkm \‚Ωu 
  ÿÔVø©A ¿Ï \_z∫ ÿÔVø©AD k´‚¶_ 
  ÿ>VaÈVÕ mkÏ©Aﬂ ∑Ák¬z""" 
       \Ú›mk >M√V¶_ 
 
ÿ√ÚzD ¿Á´ Ô‚|D ÿ>VaÁÈ mkÏ©A ∑Ák ÿƒFkÁ> ÷©√V¶_ cÏ›m˛≈m. 
 
mkÏ©A         ∑ÁkBV™m        \ı,       kπ       g˛Bku§[       ºƒÏ¬ÁÔBV_ 
 cÚkV˛•^·>V_   x›>Vm¬Ôπ_ kπ,  nBD  g˛BkuÁ≈  >[MÁÈ   ÿƒF>ÁÈ 
 ÔV‚ΩKD " ∂w_ " >VmÁk >[MÁÈ √|›mD ®[√Á> ∂§B  xΩ˛≈m. " ∂w_" >Vm 
 \mº\ÔD   ®–D   ºÂVl_   >[MÁÈ   ∏≈µkm     z§©∏¶›>¬Ôm.    "" \ı ""   Ø>D 
A≈¬ÔÚsBVF   ®[A,   ªı, g˛B   x¬˛B c¶uÔ‚|ÔÁ· cÚkV¬Ô x¬˛B √∫z 
 k˛¬˛≈m.  kπ Ø>D {¶_ , Â¶›>_, c‚ÔVÚ>_, >Vı¶_ g˛Bku§uz ÔV´\VÔ 
∂Á\˛≈m.    ¿ˆas_ ºƒVD√_ x¬˛B z§z\VÔ c^·m. 
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¿ˆa°D clÏ›>Vm¬Ô”D. 
 
 ÿ>V¶¬Ô›]_ ∂w_ >Vm, >[MÁÈ ]ˆÕm c¶uÔV∫ÁÔÁB cı¶V¬zD nB›>V
mÁk ºÔ¶ÁBﬂ ÿƒFm, ∞ø c¶_ >Vm¬Ô”D EÁ>Õm ƒ›m¬Ô^ EÆ¿Ï  
kaBVÔ ÷a•D ®™ ºÂVF ±_ √ÔÏ˛[≈m. 
 "" √ÔÏ∏›> sÕÁ>BÈVm º\ÔD k´Vm""   
®[Æ  º>Á´BÚD ºÂVF¬ÔV™ x>uÔV´›Á> cÆ] ÿƒF˛≈VÏ ®™ºk  
ºÂVF¬ÔV™  x>uÔV´›Á> ( ∂wÁÈ ) >[MÁÈ©√|›>¬ ÌΩB ∑Ák (∑Áká mkÏ©A,
 ∏ˆ° á ÷M©A) cÁ¶B ÂD >›mk ∂Ω©√Á¶l_ ÿƒB_√|k>VÔ  
∂Á\˛≈m.  
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MODERN ASPECT  
 DIABETES MELLITUS 
Definition: 
 
 Diabetes mellitus comprises a group of common metabolic disorders that share the 
phenotype of hyperglycemia. Several distinct types of diabetes mellitus exist and are 
caused by a complex interaction of genetics, environmental factors and life – style 
choices. Depending on the etiology of Diabetes mellitus, factors contributing to 
hyperglycemia may include reduced insulin secretion, decreased glucose usage and 
increased glucose production 
 
Classification 
 
 Two broad categories of Diabetes mellitus are 
 
1. Type – I diabetes (IDDM) – β cell destruction usually leading to absolute insulin 
deficiency. 
2. Type – II diabetes (NIDDM) – may range from predominantly insulin resistance 
with relative insulin deficiency  to  insulin secretory defect with insulin resistance. 
 
CLINICAL FEATURES: 
 
 Polyuria  
 Nocturia 
 Poly dipsia, dryness of mouth 
 Poly phagia 
 Rapid weight loss 
 Chronic fatigue 
 Giddiness 
Peripheral neuritis 
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Diagnostic criteria for Diabetes: 
 
Blood glucose Normal Border line Diabetes mellitus 
Fasting <0-110mg/dl >110 but less than 
125 mg% 
>126 mg % 
 
Post prandial <140mg/dl >140 But less then 
200 mg% 
>200 mg% 
 
  
MEDICAL ADVICE: 
 
1. The diet should include complex carbohydrate protein, decreased fat and low 
calories  
 
2. Advised to take small frequent meals. 
 
3. Advised to avoid sweety, excessive salty, sour tastes in food. 
 
4. Advised to take food rich in fiber content ( app 20 – 30 gm/day) 
 
5. Advised to monitor blood glucose levels regularly. 
 
CLINICAL STUDY PATTERN: 
 
 The study was carried out at the Madhumegam sirappu sigichai pura noiyalar  
pirivu (outpatient department), Government Arignar Anna  Hospital for Indian medicine 
and Homeopathy,  Chennai. 
 
Sample size:  40 Patients 
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SELECTION OF PATIENTS 
 
 Patients with the following criteria were enrolled for the study. 
 
INCLUSION CRITERIA 
 
• Patients of age group: 30-70  years 
• Patients of either sex 
• Non Insulin Dependent Diabetes Mellitus (NIDDM) – Type – II 
• Non – obese 
• Clinical Parameters – Polyuria, Polydipsia, Polyphagia, fatigue, giddiness, 
Peripheral neuritis 
 
INVESTIGATIVE PARAMETERS  
 
- Fasting blood sugar of 110/dl and above 
- Post prandial Blood Sugar 140 mg/dl and above 
 
EXCLUSION CRITERIA 
 
 Patients with type I Diabetes mellitus. 
 Pregnancy induced Diabetes mellitus. 
 Patients with renal impairment. 
 Patients with hypertension. 
 Patients with other cardio vascular problems, pancreatic pathology and liver 
affections. 
 Patients with Diabetic nephropathy and retinopathy. 
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WITHDRAWAL CRITERIA: 
  Irregular medication. 
  Patients who followed dual treatment. 
 
STUDY DESIGN: 
 
 Open clinical trial 
 
DRUG SCHEDULE: 
 
 Attiverpattai choornam, 1gm was administered with water (30ml) before food, 
twice daily for a period of 48 days. 
 
Enrollment and method of study. 
   
 Patients with us the above inclusion criteria were enrolled in the study after 
recording the baseline data.  1g of Attiverpattai choornam with water was given twice a 
day after food for a period of 48 days. The patients were advised to visit follow – up once 
in 7 days for a general observation related to dose adaptation and parallel clinical 
parameters were recorded. 
 
 The efficacy follow up was taken up at the end of 48 days of therapy for recording 
clinical and investigative parameters, and they were subjected to statistical analysis at the 
end of the study. 
 
 During the course of treatment patients were advised to report immediately when 
they get signs of hypoglycemia (giddiness, sweating, palpitation etc.) 
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Parameters of evaluation. 
 
CLINICAL PARAMETERS. 
 
• Polyuria (Athi moothiram) 
• Polyphagia (Athi Pasi) 
• Polydipsia (Athithagam) 
•  Fatigue (sorvu) 
• Giddiness 
• Peripheral neuritis 
 
 
Investigative parameter included is estimation of blood sugar (Fasting and Post 
Prandial) 
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S.No Op.No Patient Name 
Age/
Sex 
Duration of 
Treatment 
Before Treatment After Treatment 
Blood Sugar (mg%) 
 
Blood Sugar (mg%) 
F PP F PP 
1. 3343 Sivagami 56/F 29.10.07-11.12.07 136 96 201 170 
2. 2982 Gayathiridevi 32/F 31.10.07-29.12.07 140 136 234 180 
3. 3366 Ganesh 55/M 01.11.07-22.12.07 112 100 160 130 
4. 3836 Jamuna  37/F 03.11.07-30.12.07 160 136 230 170 
5. 4192 Kaveri 52/F 05.11.07-28.12.07 168 122 204 165 
6. 2678 Thangappan 49/M 10.11.07-04.12.07 110 100 180 160 
7. 5987 Devi 42/F 11.11.07-31.12.07 118 98 145 130 
8. 8263 Manimegalai 55/F 17.11.07-04.01.08 148 122 200 176 
9. 9783 Gowri  40/F 19.11.07-05.01.08 112 101 158 134 
10. 9014 Dhanalakshmi 55/F 20.11.07-04.01.08 108 102 171 155 
11. 8699 Dhanalakshmi 57/F 19.11.07-12.01.08 168 120 188 140 
12. 6107 Desigan 42/M 21.11.07-13.01.08 121 105 165 142 
13. 157 Malathi 31/F 23.11.07-14.01.08 131 116 183 156 
14. 9190 Kowsalya  48/F 23.11.07-15.01.08 140 128 185 160 
15. 1596 Adhikesavan 65/M 27.11.07-29.01.08 110 100 152 130 
16. 1580 Minnala 43/F 27.11.07-20.01.08 111 105 170 152 
17. 2785 Subbhanaidu  70/M 30.11.08-18.01.08 140 110 248 200 
18. 2909 Maniyammal 62/F 01.12.07-22.01.08 110 102 183 150 
19. 6614 Hemalatha  42/F 11.12.07-21.02.08 135 112 220 164 
20. 6772 Perumal  55/M 11.12.07-22.02.08 138 110 180 140 
21. 9220 Mary 45/F 18.12.07-26.02.08 108 102 170 140 
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22. 9431 Malliga  57/F 19.12.07-05.02.08 102 69 226 168 
23. 8600 Manonmani  44/F 18.01.08-01.03.08 130 118 168 140 
24. 8831 Dhananchezhiyan 54/M 19.01.08-04.03.08 140 124 172 148 
25. 9355 Esakiyal  55/F 21.01.08-20.03.08 128 108 197 155 
26. 9936 Sampooranam  60/F 24.01.08-11.03.08 160 124 210 141 
27. 2561 Kanagamani  39/F 29.01.08-15.03.08 138 112 180 163 
28. 2572 Johny  58/M 29.01.08-15.03.08 160 134 285 200 
29. 2558 Jamal 55/M 29.01.08-11.03.08 140 112 160 142 
30. 2427 Maniambu  62/F 29.01.08-11.03.08 135 128 183 168 
31. 3384 Pachaiammal 65/F 31.01.08-15.03.08 125 106 183 154 
32. 5310 Venkatesan  55/M 05.02.08-20.03.08 94 92 165 106 
33. 5304 Nageswararao 42/M 05.02.08-05.04.08 120 107 150 123 
34. 5318 Durai  42/M 05.02.08-20.03.08 198 121 252 201 
35. 3089 Palani 43/M 26.02.08-04.04.08 220 127 294 180 
36. 5417 Shanthi  56/F 03.03.08-15.04.08 110 102 285 183 
37. 4815 Muthuswamy 50/M 04.03.08-20.04.08 98 94 149 130 
38. 6310 Parameshwari 40/F 05.03.08-20.04.08 125 105 188 152 
39. 6357 Lakshmi 58/F 05.03.08-15.04.08 110 102 215 160 
40. 6775 Durairaj 70/M 06.03.08-19.04.08 121 106 240 165 
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SEX DISTRIBUTION
30%
70%
Male Female 
 
 
SEX DISTRIBUTION:  
  
S.No Sex No.of.Cases Percentage  (%) 
1. Male  12 30 
2. Female  28 70 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INFERENCE  
 Out of 20 Patients 12 cases(60%) were male and 8 cases (40%, were female)  
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AGE WISE DISTRIBUTION OF PATIENTS
AGE DISTRIBUTION :  
 
S.No Age Group No.of.Cases Percentage  (%) 
1. 30-40 2 17 
2. 41-50 10 25 
3. 51-60 16 40 
4. 61-70 6 15 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INFERENCE :  
 Among 40 Patients. 7 belong to age group 30-40 and 10 patients belong to age 
group 41-50, 16 pts belong to age group. 51-60 and 6 patients belong to 61-70 maximum 
pts found to be between 40-60 
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OCCUPATION WISE DISTRIBUTION 
 
S.No Occupation  No.of.Cases Percentage  (%) 
1. House wife 24 60 
2. Teacher 1 2 
3. Farmer  5 12 
4. Daily Labour  8 20 
5. Retired Person  1 2 
6. Office Work  1 2 
 
 
 
 
 
Inf
ere
nc
e:  
 
A
mo
ng 
40 
patients 24(60%) patients were housewife, 1 (2%) patient was teacher, 5(12%) patients 
were farmer and 8 (20%) were Daily Labour. From the above data, it is noted that age 
and occupation donot show any influence on the management of Diabetes.     
 
 
 
 
 
OCCUPATION WISE DISTRIBUTION
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20%
2% 2%
House wife Teacher Farmer 
Daily Labour Retired Person Office Work 
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HABIT WISE DISTRIBUTION
HABIT WISE DISTRIBUTION  
 
S.No Habit  No.of.Cases Percentage  (%) 
1. Veg  6 15 
2. Mixed  18 45 
3. Alcohol  8 22 
4. Smoker  8 22 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INFERENCE :  
 This table shows that food habit do not show any influence in case of Diabetes. 
Among 40 patients. 6(15%) were, Vegetarian, 18%(45%) were non-veg, 8(22%) were 
smoker 8(22%) were alcoholic 8 (22%) were smokers.   
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SOCIO- ECONOMIC STATUS
71%
22%
7%
Poor Middle Rich 
SOCIO- ECONOMIC STATUS:  
 
S.No Socio – Economic Status  No.of.Cases Percentage  (%) 
1. Poor  28 71 
2. Middle 9 22 
3. Rich  3 7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INFERENCE :  
Among 40 pts 28(71%) were poor, 9(22%) were middle class and 3 (7%) were  
rich.  
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SYMPTOM WISE DISTRIBUTION
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SYMPTOM WISE DISTRIBUTION 
 
Symptoms Before 
Treatment 
After 
Treatment 
Improvement Percentage 
(%)  
Polyuria 40 4 36 90 
Polydipsia 40 3 37 92 
Polyphagia 39 4 35 89 
Giddiness 34 6 28 82 
Fatique 40 10 30 75 
Peripheral 
Neuritis 
23 14 9 39 
 
 
 
 
 
 
 
 
 
 
INFERENCE:  
 Patients with the parameters that is polyuria, Polydipsia, Polyphagia, Giddiness, 
Fatigue, Peripheral Neuritis were taken for the study.  
Among 40 Patients 36 pts improved from polyuria.  
Among 39 Pts with polyphagia 35 got relief from the symptom. 
Among 40 Pts with polydipsia 37 improved.  
Among 34 Patients with giddiness 28 got relief, Among 40 Pts with Fatigue 30 got 
improvement, Among 23 Pts with peripheral neuritis only 9 got improvement.  
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MEAN VALUES OF REDUCTION IN BLOOD GLUCOSE LEVELS:  
Before and After Treatment 
 
S.No Blood Sugar 
Before 
Treatment 
After 
Treatment 
Reduction 
1. Fasting  133 107 26 
2. Post Prandial  195 155 40 
 
INFERENCE :  
 
 The mean Value of reduction in fasting blood sugar level before treatment 26. The 
mean value of reduction in post prandial sugar level after treatment 40. 
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METHODOLOGY FOR STATISTICAL ANALYSIS  
 
PHARMACOLOGICAL STUDY:  
 
The statistical analysis was carried out by using one-way ANOVA (Analysis of 
variance) followed by Dunnett’s ‘t’ test. P values <0.05 were considered as significant.  
 
STATISTICAL ANALYSIS FOR CLINICAL STUDY:  
 
To find the statistical significance paired t-test was used to assess the effect of 
treatment based on symptoms. Two tailed P value was considered for statistical 
significant. Analysis was performed by using SPSS 10 (Statistical Package for social 
science) Version package. For comparison of  proportion among male and female less 
than 45 years and greater than or equal to 45 years. Chi square test was applied to find the 
statistical significance. P values less than 0.05 were considered significant.  
   
 
 
 To study variation in one or more attributes the data are expressed mostly as 
proportions. If a sample is divided into only two classes such as successes and failures it 
is said to have a binomial  
 
   Number of individuals having a Specific Character  
P =   
      Total Number  
   Character in a binomial distribution is expressed   
P =   
      Total Number  
  q = probability of non – occurrence of the same . 
 
STANDARD ERROR OF PROPORTION (S.E.P)  
t       =  
d √n   
S 
d – Mean  
n – No.of Samples  
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 The probability or Proportional changes of positive or negative occurence of an attribute 
or a character in a population or universe follows. 
 
 Binomial Frequency Distribution  
      Pq  
      N  
  
Probability of difference occuring by chance can be found by applying Z test as done in 
the case of means,   
                 p – P  
   S.E.P 
 
STATISTICAL ANALYSIS 
 
DESCRIPTIVE STATISTICS :  
 
 N Minimum Maximum Mean 
Standard 
Deviation 
Age 40 31 70 50.5 12.36 
The mean value of Affected group was observed to be 50. 
 
PAIRED SAMPLES STATISTICS:  
 
Pair I 
Fasting 
Blood 
Sugar 
N Minimum Maximum Mean Standard Deviation 
B.T  
 
A.T 
40 
 
40 
94 
 
96 
220 
 
200 
131.95 
 
110.35 
25.85 
 
13.5 
The mean Fasting Blood Sugar (131.95) before treatment was reduced to mean value 
110.35 after treatment.  
 
 
 
√S.E.P =  
Z =  
 61
PAIRED SAMPLES STATISTICS:  
 
Pair I 
Post 
prandial  
Blood 
Sugar 
N Minimum Maximum Mean Standard Deviation 
B.T 
 
A.T 
40 
 
40 
149 
 
123 
294 
 
207 
195.72 
 
155.52 
30.01 
 
20.82 
 
The mean Post prandial Blood Sugar (195.72) before Treatment was reduced to mean 
155.53 after treatment.  
  
Pair  B.T vs A.T Paired Mean  t df  
Significance 
(2 tailed) 
1. Fasting Blood Sugar  18.9 6.250 39 0.000 
2. Post Prandial blood Sugar  41.125 10.582 39 0.000 
 
Paired t-test showed significant (P<0.001) in both fasting and Post prandial blood 
sugar levels after treatment at 39 degrees of freedom. The Attiverpattai choornam has 
produced significant reduction in both Fasting and Post prandial Blood Sugar level.  
 
STATISTICAL ANALYSIS OF SUBJECTIVE PARAMETERS OBSERVED 
BEFORE AND AFTER TREATMENT OF PATIENTS.  
 
S.No Parameters 
Percentage improved Statistical 
Criteria 
Probability Significance
Study  Effect Difference 
1. Poly uria  100 90 10 Z=0.645 P<0.001 Significant  
2. Polydipsia  100 93 7 Z=0.3225 P<0.001 Significant  
3. Polyphagia  97 88 9 Z=0.000 P<0.001 Significant  
4. Giddiness 85 70 15 Z=1.225 P<0.001 Significant  
 
P <0.001 hence the improvement in the subjective parameters produced by Attiver pattai 
choornam is statistically significant.  
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DISSCUSION 
 
 Madhumegam (Diabetes mellitus) represents a heterogeneous group of disorders. 
It is characterized by hyperglycemia and disturbances of carbohydrate, fat and protein 
metabolism associated with absolute or relative deficiencies in insulin action or insulin 
secretion. 
 
 From the literature survey the drug Attiverpattai choornam was found to be 
Attiverpattai choornam was found to be more effective in the treatment of 
Madhumegam. 
 
The drug was selected as per the literature evidence given in the siddha text 
“Vaidhiya perungural” and clinical trial, pharmacological shady were carried out in 
order to prove its efficacy   in treatment of Madhumegam. 
 
 The various experiments studies on Attiverpattai (The root bark of Ficus 
racemosa linn shows its potent hypoglycemic activity. 
 
∂›]ºkÏ©√‚Á¶    mkÏ©A     ∑ÁklÁ™•Á¶Bm,   
 
  mkÏ©A   ∑Ák = ∏Ú]s + kV• g˛B Ø>∫ÔÁ· cÁ¶Bm.  
 
∏Ú]sl[ √ıA  
 
 ∏Ú]sl[ √ı√V_ kV>›]™VKD, ÿƒÕ¿ˆ™VKD, ∏≈¬zD Ô‚ΩBV˛B  
÷´∫Ô”D, kV>© ÿ√VÚ\KD º√VzD.  
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kV•s[ √ıA :  
 
 t¬Ô ¿Ïºk‚ÁÔ, c¶_ ∂™_, ºƒVÏ° g˛BÁkÔÁ·› >Ë¬zD.  
 
 "" º\Ô¬ Ô|©Á√ sÁ·s¬zD T§W[≈  
   >VÔ \™oÁ·©Á√ﬂ ƒVÕ] ÿƒF•D  
 ................................................................ 
 .................................................................. '' 
      √>VÏ›> z EÕ>V\Ë  
mkÏ©∏[ ÷B_A:  
 
 Ô‚|¬Ô¶∫ÔV\_ ÿkπBVzD \ÈD, ¿Ï, zÚ] x>ÈV™ÁkÔÁ·¬ Ô‚Ω  
\‚|©√|›] WÆ›mD. ∏›>›Á> º√V¬zD. x¬zu≈›>V_ c¶o_ º>V[§B  
÷´∫ÔÁ· guÆD. Ô√›Á> º√V¬zD.  
 ®™ºk mkÏ©A ∑ÁklÁ™•Á¶B ∂›]ºkÏ©√‚Á¶ \mº\Ô›][  
z§z∫Ô·V˛B ¿Ïºk‚ÁÔ, ºƒVÏ°, ∂]J›]´D g˛B z§z∫ÔÁ·¬  
º√V¬Ô¬ÌΩBm. º\KD ∏›>›Á>•D, Ô√›Á>•D ƒ\©√|›] ºÂVl[  
z§z∫ÔÁ· zÁ≈¬Ô¬ÌΩB >[Á\•Á¶Bm.  
   "" √ÔÏ∏›> sÕÁ>BÈVm º\ÔD k´Vm''  
-   º>´Ï  
 
cs[ ºkÆ√V‚¶VKD, >ÔV> ÿƒB_Ô·VKD ∏›> >Vm ºÔ¶Á¶Õm        ∂>uz 
mÁBVÔ \u≈ zu≈∫Ô”D ºÔ¶Á¶Õm º\Ô›]Á™ ∏≈©∏¬zD.  
 
 mkÏ©A ∑ÁkBV™m ∏›>Ô√ º>V¶∫ÔÁ· ƒ\©√|›mD.  
 
 
 The physiochemical standardization viz. Total acid soluble ash, water soluble ash, 
alcohol and water soluble extractive values were determined. 
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 In Diabetes mellitus due to the insufficiency of insulin the normal protein 
synthesis of the body is affected. Hence there is loss of weight which should be treated 
with dietary protein supplement. Hence the presence of protein is a significant evidence 
for the treatment of the disease.  
 
 Flavonoids are potent anti- oxidant when body’s cells burn oxygen they form free 
radicals. Increased formation of reactive oxygen species (ROS) related to increase of 
glucose concentration in plasma and tissues. The inhibitory effect may be due to 
flavonoids. 
 
 Bio markers for oxidative damage to DNA, lipids and proteins are also supporting 
the concept of increased oxidative stress in diabetes. Antioxidant treatment can reverse 
oxidative stress, suggesting the therapeutic procedure beneficial effect of antioxidant 
treatment.  
 
 The β – sitosterol-D glucoside of Ficus racemosa is hypoglycemic. (MAPIS June 
1986, No. 1474). 
 
 Extract of the bark Ficus racemosa linn reduces blood sugar by 62% due to 
presence of same carbohydrates and amino acids which are ant diabetic.( The Doctor 
News, Jan 1991) 
 
 The biochemical analysis of the drug showed the presence of Zinc. The quantity of 
Zinc per kg was 37.8mg. Zinc is essential constituent of many enzymes such as Carbonic 
anhydrate, Alkaline phosphates, pancreatic carboxy peptidase and cystolic super oxide 
dismutase.  
 
 Zinc is required for the preparation of insulin and increases the duration of  insulin 
action, when given by injection. Zinc is used in the β cells of the pancreas to store and 
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release insulin when required. Hence the presence of Zinc supports its efficacy in the 
management of Madhumegam. 
 
 Chloride is necessary for glandular hormone secretion. It also prevents the 
building of excessive fat and acute intoxication. It many be helpful in preventing the 
athreselerotic changes due to diabetes. 
 
 Antimicrobial study reveals that the drug is a highly sensitive anit – bacterial agent 
against Staphylococcus aureus, Mutans, Pseudomonas, Klebsiella and E.coli. 
 
 Acute and repeated oral toxicity study reveals that the drug was proved safe for 
administration as it did not exhibit any significant toxicity at 600mq/kg body weight. 
 
 Attiverpattai choornam produced hypoglycemic activity against alloxan induced 
diabetic rats. The findings of the experimental anti diabetic study show that Attiverpattai 
possess anti diabetic property and thus lead pharmacological support to the traditional 
Siddha medical use of Attiverpattai choornam in treatment of Madhumegam. 
 
 Open clinical trial with a sample size of 40 Patients, a period of 48 days revealed 
the following features.  
 
 Max. No. of patients affected belong to the age group 40-60 (65%) and the greater 
being female (70%). Patients taking mixed diet (45%) were more prone to the incidence 
of Madhumegam. It was found that sedentary life style and habits influences the 
occurrence of Madhumegam. 
 
 Administration of Attiverpattai choornam, 1gm twice a day with water (30ml), 
before food for a period of 48days, showed gradual relief from the subjected parameters 
such as Polyuria (Athimoothiram), Polydipsia (Adhidhagam), Polyphagia (Adhipasi) and 
fatigue (Sorvu), Improvement in the subjected  parameters were clinically significant, 
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statistical analysis showed significant reduction  in both fasting and  post prandial blood  
sugar after treatment with Attiverpattai choornam. No adverse effects were observed 
during the entire course of this study. 
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SUMMARY 
 
 The study on Attiver Pattai Choornam to evaluate its efficacy in the 
management of Madhumegam was carried out based on the evidences collected from 
Siddha literatures. 
 
After obtaining guidance from the HOD & permission from principal, Govt 
Siddha medical college, pharmacognostical study was carried, out in Central Research 
Institute for Siddha, Chennai – 106. 
 
 Pharmacological study was carried out in C.L. Baid Metha College of pharmacy, 
Thoraipakkam, Chennai. 
 
The single drug Attiverpattrai was purified, powdered and purified, prepared as 
choornam and was stored. RF values were determined by TLC. 
 
Phytochemical tests were done which showed the presence of Tannins, Steroids, 
Flavanoids, Saponins, Proteins, Amino acids and Glycosides. 
 
The antimicrobial study proved, it to be effective against various bacteria. 
  
Biochemical analysis showed presence of calcium, Iron (ferrous), phosphate, and 
chloride.  
 
Pharmacological study was done for its ant diabetic activity in C.L Baid Mehta 
College of pharmacy, Chennai, Thoraipakkam. The results showed significant 
hypoglycemic activity on alloxan induced diabetic rats. 
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The clinical assessment was done as an open clinical trial in special op department 
for Madhumegam at Arignar Anna Hospital for Indian medicine Chennai – 106. The 
patients were selected according to selection criteria. 
 
Patients were carefully observed in regular visit and prognosis was sincerely 
documented. 
 
 The drug Attiver Pattai Chooranam was administered 1gm twice a day with water 
(30ml) before food for a period of 48 days. 
 
 In the clinical trial improvement of signs and symptoms like polyuria, polydipsia, 
polyphagia, fatigue were clinically significant. 
 
 No adverse drug effect was observed during the entire course of study. 
 
 The drug Attiverpattai choornam showed significant reduction in blood sugar. 
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CONCLUSION 
 
 The evaluation of efficacy of a single drug, Attiverpattai choornam in the 
management of Madhumegam gave significant results. 
 
 Presence of Tannins, Flavanoids Saponins, Zinc, Chloride  play a vital role in 
management  of Madhumegam. 
  
 Pharmacological anti- diabetic activity strengthen the study. 
 
 Clinically the drug relieved the symptoms polyuria, polydipsia, polypnagia very 
well. 
 
 Attiver pattai choornam regularized the 3 humors by stabilizing the azhal thathu 
by its thuvarpu suvai 
  
 No adverse effects were observed during the period of study.  
 
 In total Attiver pattai choornam play a potential therapeutic role the in 
management of Madhumegam. 
 
 Attiver pattai choornam needs further study with regard to mechanism of action 
to develop as a potent anti diabetic agent. 
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SEX DISTRIBUTION:  
  
S.No Sex No.of.Cases Percentage  (%) 
1. Male  12 30 
2. Female  28 70 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INFERENCE  
 Out of 20 Patients 12 cases(60%) were male and 8 cases (40%, were female)  
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AGE WISE DISTRIBUTION OF PATIENTS
AGE DISTRIBUTION :  
 
S.No Age Group No.of.Cases Percentage  (%) 
1. 30-40 2 17 
2. 41-50 10 25 
3. 51-60 16 40 
4. 61-70 6 15 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INFERENCE :  
 Among 40 Patients. 7 belong to age group 30-40 and 10 patients belong to age 
group 41-50, 16 pts belong to age group. 51-60 and 6 patients belong to 61-70 maximum 
pts found to be between 40-60 
OCCUPATION WISE DISTRIBUTION 
 
S.No Occupation  No.of.Cases Percentage  (%) 
1. House wife 24 60 
2. Teacher 1 2 
3. Farmer  5 12 
4. Daily Labour  8 20 
5. Retired Person  1 2 
6. Office Work  1 2 
 
 
 
 
 
Inf
ere
nc
e:  
 
A
mo
ng 
40 
patients 24(60%) patients were housewife, 1 (2%) patient was teacher, 5(12%) patients 
were farmer and 8 (20%) were Daily Labour. From the above data, it is noted that age 
and occupation donot show any influence on the management of Diabetes.     
 
HABIT WISE DISTRIBUTION  
 
S.No Habit  No.of.Cases Percentage  (%) 
OCCUPATION WISE DISTRIBUTION
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HABIT WISE DISTRIBUTION
1. Veg  6 15 
2. Mixed  18 45 
3. Alcohol  8 22 
4. Smoker  8 22 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INFERENCE :  
 This table shows that food habit do not show any influence in case of Diabetes. 
Among 40 patients. 6(15%) were, Vegetarian, 18%(45%) were non-veg, 8(22%) were 
smoker 8(22%) were alcoholic 8 (22%) were smokers.   
 
 
 
 
SOCIO- ECONOMIC STATUS:  
 
SOCIO- ECONOMIC STATUS
71%
22%
7%
Poor Middle Rich 
S.No Socio – Economic Status  No.of.Cases Percentage  (%) 
1. Poor  28 71 
2. Middle 9 22 
3. Rich  3 7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INFERENCE :  
Among 40 pts 28(71%) were poor, 9(22%) were middle class and 3 (7%) were  
rich.  
 
 
 
SYMPTOM WISE DISTRIBUTION 
 
SYMPTOM WISE DISTRIBUTION
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Symptoms Before 
Treatment 
After 
Treatment 
Improvement Percentage 
(%)  
Polyuria 40 4 36 90 
Polydipsia 40 3 37 92 
Polyphagia 39 4 35 89 
Giddiness 34 6 28 82 
Fatique 40 10 30 75 
Peripheral 
Neuritis 
23 14 9 39 
 
 
 
 
 
 
 
 
 
 
INFERENCE:  
 Patients with the parameters that is polyuria, Polydipsia, Polyphagia, Giddiness, 
Fatigue, Peripheral Neuritis were taken for the study.  
Among 40 Patients 36 pts improved from polyuria.  
Among 39 Pts with polyphagia 35 got relief from the symptom. 
Among 40 Pts with polydipsia 37 improved.  
Among 34 Patients with giddiness 28 got relief, Among 40 Pts with Fatigue 30 got 
improvement, Among 23 Pts with peripheral neuritis only 9 got improvement.  
MEAN VALUES OF REDUCTION IN BLOOD GLUCOSE LEVELS:  
Before and After Treatment 
 S.No Blood Sugar 
Before 
Treatment 
After 
Treatment 
Reduction 
1. Fasting  133 107 26 
2. Post Prandial  195 155 40 
 
INFERENCE :  
 
 The mean Value of reduction in fasting blood sugar level before treatment 26. The 
mean value of reduction in post prandial sugar level after treatment 40. 
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INTRODUCTION 
 
 
 Use of traditional Medicines for human ailments, especially herbal medicines, 
could be traced back to 4500 BC in ancient China at the time of Xia dynasty and in India 
during the vedic period.  With increasing life expectancy, incurable chronic diseases 
toxicity associated with modern systems of medicines, traditional systems of medicine 
have become significantly popular all over the world today. 
 
 The World Health Organization (WHO) estimates that 80% of the Population of 
developing countries relies on traditional medicines for their primary health care.  The 
world market for herbal products is estimated at $ 80 billion dollars and is growing at the 
rate of 7 % per annum. 
 
 Life is not mere living but living in good health. The health of an individual and of 
nations is of primary concern to one and all. From his first awakening man has sought to 
fight and control diseases and turned to nature for inspiration and guidance. 
 
 During thousand of years of early existence many natural materials by instinct or 
intuition or trial and error, got in use for combating human ailments.  Thus the 
Traditional systems of Medicines Siddha, Ayurveda lean heavily on natural products in 
health management. 
 
 In spite of great and spectacular advances in modern medical sciences in the fight 
against disease, a considerable portion of world’s population, especially in developing 
countries like India is still without proper medical care. 
 
 About one third of India’s population have never visited a doctor and another 24 
% doesnot get proper medical treatment.  Hence practicing siddha system of medicine 
and usage of medicinal plants for curing ailments such as inflammation, jaundice, 
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diabetes mellitus are gaining momentum throughout the world.  Siddha system of 
medicine claim to offer a number of herbal medicines that are effective in curing such 
diseases permanently without or with minima side effects.  But scientific and 
experimental evidences to support these claims are meager. 
 
 There has been resurgence of Siddha System of medicine the world over .  There 
is growing realization in the world that the holistic approach of Siddha System of 
medicine complimenting the modern systems holds the key for realising the goal for 
health and well being for all. 
 
 The Siddha System of medicine have an impressive record of treating many 
chronic and incurable diseases. “Vellainoi” (Leucorrhoea) is one such ailment of 
womanhood.  The treatment of Vellainoi has become a great problem since many women 
refuse to present themselves with such complaints. 
 
 “Gandagam” (Sulphur) is widely used in Siddha System for treating various 
diseases especially skin diseases. Hence an attempt was made to find out the efficacy of 
“Gandaga Parpa Matirai” in treating Vellainoi. Systematic pharmacological studies in 
evidence to the study have been made out. 
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AIM AND OBJECTIVES 
 
AIM:  
 To evaluate the efficacy of Gandhaga Parpa Mathirai in the management of 
Vellai Noi.    
 
OBJECTIVES:  
 
 To Identify the Crude drug  
 To study the Antimicrobial activity of the drug 
 Bio Chemical analysis of the drug  
 To study the Acute oral toxicity of the drug  
 To study the Pharmacological activity  of the drug (Anti-Inflammatory, Analgesic)  
 To evaluate the efficacy of the drug clinically  
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REVIEW OF LITERATURE  
GUNAPADAM ASPECT 
 ÔÕ>ÔD  
 
ºkÆ ÿ√BÏÔ^:  
 
 "" sÕ>V™ ÂV>ÿ\[ÆD cÔV´º\[ÆD º√Ú 
  s·¬˛º™VD º>EÿB[ÆD ºÔƒˆÿB[ÆD  
   x›>V™ JÈÿ\[ÆD QV™ÿk[ÆD º√Ú 
  J>ı¶¬ ºÔV>ı¶ÿ\[ÆD º√Ú 
  ÂÕ>V™ \Ô´E∫˛ÿB[ÆD º√Ú 
  \ÁÈ ÂV>ÿ\[≈>uz ÿ√B´Vﬂ∑  
 ∂Õ>V™ ÷Õ>©√Ω ∂§Õº> ÿƒV[º™VD 
  ∂§Õm^º·VÏ ®[™V>D ∂]>©º√º´45"" 
             
sÕmÂV>D, cÔV´D, º>E, ºÔƒˆ, x›>V™ JÈD, QV™D, J>ı¶D,  
ºÔV>ı¶D, \ÔV´ E∫˛, \ÁÈÂV>D, ®™ ÷]_ ÿ√Bˆ¶©√‚|^·m.  
 
"" ÔÕ] ÿ√V[ kÏ∫ ÔVˆÁw ÂV>\VD  
  ∂Õ]√ ÂVÆDØk] ´ﬂ∑º´VË›  
  >Õ]B ƒ›]>[ \V>¬zﬂƒÈVD  
  √Õ]B ÿÔÕ>Ô© √ˆ√VÁ≠ ÂV\º\'' 46  
    á ƒ‚¶xM WÔı|  
 
 ÔVˆÁwl[ ÂV>D, √Á´ TˆBD, ∂y>© ∏´ÔVƒD, ¨¤D, ÿƒ_ssÕm, 
ƒ¬], ƒ¬] ¨ƒD, ÿƒÕ#´›>V],  >™D, º>s•´D, ÂVu≈D, √ˆ ÂV>D,  
ÿ√V[kÏË, ÷´ƒ ∑º´VË>D ®™°D ∂Áw¬Ô©√|˛≈m2. 
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 Ôs, zﬂƒ_, zÚÕ>ÔD, ÿƒ·ÔD >kËBD, ]´Vƒ>D, ØÏk√‚ƒD,  
\´>D ®™ ÷>[ ÿ√BÏÔ^ Ák›]B kw¬˛KD kV> kw¬˛KD ∂>[  
>[Á\Ôº· z§©√VÔ ÿƒV_È©√‚ΩÚ¬˛[≈™3. 
 
ÔÕ>Ô›][ ∏≈©A: 3 
 
 x‚Á¶l[ ÿk^Á·¬ÔÚ, ÿk^c^π, ÿk∫ÔVBD, x>oBku§_  
ÔÕ>ÔD n¬˛B©√‚ΩÚ¬˛≈m. g™V_ ÿ√ÚD√V[Á\BVF ÷m ÷ÚDA,ÿƒDA,~BD,g˛B 
cºÈVÔ∫Ôº·V| ºƒÏÕ]Ú¬˛[≈m. ÷©√Ωﬂ ºƒÏÕ]Ú©√Á>  
kÆ›m ÔÕ>Ô\V™m ®|›m¬ ÿÔV^·©√|D.  
 
 #FÁ\BV™ ∏≈sﬂ ƒ´¬ÔV™m ∂¬˛M \ÁÈBΩkV´∫ÔπKD 
Øtl_ ∂ºÂÔ ÷¶∫ÔπKD ∂Ô©√|D. x¬˛B\VF EEo, ÷›>Vo x>oB  
ÂV|Ôπ_ ÷ÚÕm ÿÔVı| k´©√|D ÔÁ¶l_ suÔ©√|D ÔÕ>Ô›]_ ∂BD,         ÂVÔD, 
√V¶VD, ∑ıVDA x>oB º>V¶∫Ô^ c^·™. gÁÔBV_ ÷Á>       cÚ¬˛BVkm 
kVÁÈlo‚| ÷≈¬˛BVkm √>∫˛›>Vkm #FÁ\ ÿƒFB  
ºkı|D.  
 
 ¤VoW•¸ ®[≈ k_KÂÏ Ek©A¬ ÔÕ>ÔD, \ﬁƒ^ ÔÕ>ÔD, ÿk^Á·        
ÔÕ>ÔD, ÔÆ©A¬ ÔÕ>ÔD ®[ÆD ÂV[z kÁÔÔÿ·[Æ  Ì§•^·VÏ.  
 
ÔÕ>Ô›][ E≈©∏B_AÔ^:3  
 
1. ÔÕ>ÔxD ÷´ƒ›Á> º√VÈ ∞ÔØ>\]Ôˆ›> ƒ´¬z,  ÷>[ ∏≈©AD  
÷´ƒ›Á> º√VÈºkBVD, g™V_ kıº√>D cÚkº√>D g˛B™         c^·™
. ÷©º√>∫Ô^ ∂>[ sÁ· WÈ∫Ôπ[ z∫Ôº·BVzD.  
 
2. ÔÕ>Ô›]_ º>•s[ zD E≈©√VÔ ÷Ú¬˛≈m. ÷¬ÔV´D √u§ºB  
ÿƒVu√ﬂ Û‚¶VKD ∂m cÆ˛s|˛≈m.  
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3. ÷m ƒÕ]´ ƒD√Õ>\V™m. ÷´ƒ\V™m ÛˆB ƒD√Õ>xÁ¶Bm.  
gÁÔBV_ ÷Às´ıΩuzD ƒ¬] Ekÿ\[ÆD Ák›]B kw¬˛_  
kw∫Ô©√|˛[≈™.  
4. ÷´ƒ›Á> º√VÈºk ÔÕ>ÔxD >‚√ÿk©√ ºÂVFÔπKD, \uÿ≈_ÈV  
ºÂVFÔπKD c√ºBVÔ\V˛[≈m.  
5. ŒÚkÁÔl_ ÔÕ>\V™m ÷´ƒ›Á>¬ ÔV‚ΩKD º\[Á\BV™m  
∞ÿ™M_ ÷´ƒ›Á> >MºB ÿÔV|›>V_ kVF ∏Ω¬Ô ÿƒF•D zD 
 c^·m. 
6. xÁ≈©√Ω ÿƒFB©√‚¶ ÔÕ>Ô√u√\V™m ®ıkÁÔ ÿ√ÚD ºÂVFÔ·V™       z‚¶D, 
z[\D, √Vı|, ƒBD, ÿ√ÚºÂVF, zÁ≈ºÂVF x>oB ∂ºÂÔ          ºÂVFÔÁ· yÏ
¬˛[≈™. 
7. ÔÚ∫z‚¶D, ÿkız‚¶D, ÿƒ∫z‚¶D x>oB ∂ºÂÔ z‚¶  
kÁÔÔÿ·_ÈVD ÔÕ>Ô √u√›Á> Ôı¶V_ ŒΩs|D.  
8. √ÈkÁÔ Âﬁ∑Ô^ ÷>™V_ yÚ˛[≈™. √ﬂÁƒ ÂV∏, ÔÚÂV∏,  
√V¶VD, ∂∏M x>oB Âﬁ∑Ôÿ·_ÈVD x§Õm yÏÕm º√V˛[≈™.      ÷[–D
 Ák›]B ºÂVF, ∏´Á\ ºÂVF x>oBÁk•D ÷>™V_  
yÚ˛[≈™.  
9. xÁ≈©√Ω ÿƒFB©√‚¶ ÔÕ>Ô xÁ≈l™V_ g•^sÚ›], y√™  
sÚ›], QV√Ô ƒ¬] sÚ›] cı¶VzD.   
10. ÷´ƒ\V™m ÔVB∑›], ÔVBE›] g˛BkÁÔÔ”Ôz ∂kEB\V™m.  
÷m º√VÈºk ÔÕ>ÔxD ÷[§BÁ\BV>m.  
 
ÔÕ>Ô›][ kÁÔÔ^: 3 
 
 ÷]_ ÂV[z kÁÔÔ^ ÔÁ¶l_ suÔ©√|˛[≈™. 1. kV ÔÕ>ÔD  
∂_Èm zwVF ÔÕ>ÔD, 2. ÿÂ_o¬ÔVF ÔÕ>ÔD, 3. √ﬂÁƒ ÔÕ>ÔD,  
4. √Ú©A¬ ÔÕ>ÔD.  
 ÿÂ_o¬ÔVF ÔÕ>ÔD, √Ú©A¬ ÔÕ>ÔD g˛B ÷´ı|D ƒV©∏|D  
\ÚÕmÔπ_ x>[Á\BV™m.  
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 kV ÔÕ>\V™m º\uØﬂ∑ \ÚÕ]_ c√ºBVÔ©√|˛≈m.  
 Ek©A¬ ÔÕ>ÔD ÷´ƒkV> xÁ≈Ôπ_ √B[√|˛[≈m.  
 
z√V¶D >Vm kz©∏[ √Ω ÷>[ kÁÔÔ^: 2 
 
1) ÿkıÁ\ W≈›Á>•Á¶Bm ®_ÈV ºÂVFÔÁ·•D yÏ¬zD.  
2) ˛π J¬z Ek©A W≈›Á>•Á¶Bm ÂkºÈVÔ›Á> ∞\\V¬zD.  
3) ÿkıÁ\ W≈xÁ¶Bm zu≈ \u≈ ÿÂ_o¬ÔVF º√V[Æ ÷Ú¬zD  
Û>Ô› º>V| c≈kV˛ ∑›>\VF ÷Ú¬zD.  
4) ÔVÔ›][ W≈›Á>•Á¶Bm, ∂Ô©√¶Vm ∂Ô©√‚¶V_ ÂÁ´, ]Á´  
∂uÆ©º√VD,  
\ÚÕmÔπ_ ÁÔBV·©√|km ÿÂ_o¬ÔVF ÔÕ>ÔD \‚|º\.  
 
√ÁÔ Â‚Aﬂ ƒ´¬z:   
 
 "" ÿƒV_Kº\ >VD∏´›Á> ÿÔÕ] ÿÔV_KD""  
 "" ÔÕ]¬˛™x t´ƒÕ>V ÿ™[≈Vº´''  
®[≈ ∂ΩÔ·V_ ÷>[ √ÁÔ, Â‚Á√ ∂§BÈVD.  
 
∑Ák :  
 ÁÔ©A, mkÏ©A.  
 
ÿƒFÁÔ :  
 1. ∏›>¿Á´ ∂]Ô©√|›mD ÿƒFÁÔ.  
 2. \È t·¬˛  
 3. c¶_ º>u§  
 4. sBÏÁk ÿ√Ú¬˛  
 5. ˛Út ÂVEM  
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ÿ√Vm zD :  
 
 E§B ∂·s_ ÔÕ>Ô›Á> c^”¬z ∂ÚÕ> ∂‡m c¶D∏_ ºƒÏÕm          sBÏÁ
k, √V_, EÆ¿Ï ÷ku§[ kVlÈVÔ ÿkπ©√|D.  º>V_, ∂∑Ô∫Ôπ[  
ƒπ ƒÀsK^· ºÔV·∫Ôπ[ ∑´©Á√ ∂]Ô©√|›mD, sº´˛l_ E≈©√VÔ  
ÿƒB_√‚| ∑´©Á√ ∂]Ô©√|›mD, ∂]Ô ∂·s_ ∂ÚÕ> º√] cı¶VzD.  
 
ÿÂ_o¬ÔVF ÔÕ>ÔD :  
 
 "" ÿÂ_o¬ÔVF¬ ÔÕ]¬z ¿^√]ÿ[z‚¶D \Õ>D  
  k_ÁÈ ÔsÁƒz[\ kV•ÔıºÂVF  ÿ√V_ÈV  
 s¶¬ÔΩ k[ º\ÔºÂVF TÆ∑´D º√]  
 ]¶¬˛´ÔË Ô√D º√VÕ º>Ï ""  
 ÷>™V_ √]ÿ[z‚¶D, \Õ>D, Ô_‹´_ T¬ÔD, ÿ√ÚklÆ, z[\ 
kV•, ÔıºÂVF, s¶¬ÔΩ, ÂV‚√‚¶ º\ÔºÂVF, kV> ∑´D, º√], ÂV‚√‚¶  
˛´ÔË, Ô√D ¿∫zD.  
 
E≈©A: 2 
 ÔÕ>ÔD >VF \ÔÁk k·Ï©√m º√VÈ ºÂVFÔπ[ ÿk©√›Á> \Vu§  
c¶DÁ√ º>uÆs¬zD.  
 "" \V>u \ÔÁk k·Ï©√m º√VºÈ c¶DÁ√  
  BV>´kV Ô›º>u§ BV¬ÁÔl™V_ *>VÔ  
 º\s B¶u ºÂVl[ ÿk©√›Á> \VuÆ>ÈVu  
 º>s•≈ ÿ\[√m¶_ º>Ï""  
 
÷>™V_ Ô‚Ω, ÿƒV§, E´∫z, ˛´Õ], z‚¶D, zasøD ´∫Ô^ k‚¶t‚|  
kÚD ÿƒD√Á¶, ÔÚD√Á¶ x>oB™ yÚD.  
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 kV>., ∏›>D, EºÈ›m\D g˛B J[Æ kÁÔ º>V¶∫ÔÁ·•D ¿¬zD,  ÷´›>ÔVƒD
 ÿ√ÚºÂVFÔ^, \ıß´_ ºÂVF g˛BkuÁ≈ ÔıΩ¬zD ÿƒV§,E´∫z, AıÔ^, s´
∫Ô^ x>oB º>V_ ºÂVFÔÁ· ÔıΩ¬zD. Âﬂ∑ OıAø¬ÔÁ· ÂVƒ\V¬zD.   \È›Á>
l·¬zD.  ÷´›> sÚ›]ÁB cı¶V¬˛ xmÁ\ >[Á\ÁB º√V¬zD.  
 
ÔÕ>Ô›][ ∑›] xÁ≈Ô^:   
 
 AπBD√w {‚Á¶ √u§lÚ¬zD ÔEÁk ª≈ Ák›> ¿Ï, ÔVΩ ¿Ï, Aπ›> º\VÏ,        
      ÔV·V[ ƒVÆ ÷ÁkÔÁ· >M >M 6 √È\VÔ ®|›m ÔÈÕm ŒÚ ƒ‚Ωl_ ÷‚|          
     ∂ﬂƒ‚Ω¬z ÊÁÈl™V_ ºk|Ô‚Ω ∂>[º\_ ŒÚ √ÈD (35˛) ÔÕ>Ô›Á> Ák›m  
     º\_xΩ y√V¬˛MBVF ÷´ı| ƒV\D ®ˆ¬Ô \o™D º\_ >∫˛ ÔÕ>ÔD ∑›]BV˛   
     ˇa≈∫zD.  
 
 \Úº>V[§ Ô_Ô›Á> √∑s[ >lˆ_ ÔÈÕm ŒÚ ƒ‚Ωlo‚|ﬂ ÊÁÈBV_  ºk|       
      Ô‚Ω º\_ ÔÕ>Ô›Á> Ák›m \uÿ≈VÚ ƒ‚ΩBV_ JΩﬂ ÊÁÈ ÿƒFm zal_            
      AÁ>›m º\_ ƒ‚Ωº\_ 5 k´‚Ω ÿÔVı| A¶t¶ ÔÕ>ÔD cÚ˛¬ ˇa≈∫zD.            
      ÷Às>D 7 xÁ≈ ÿƒFBÈVD.  
 
 ÔÕ>Ô›Á> ŒÚ ÷ÚDA¬ Ô´ıΩlo‚| E§m √∑ ÿkıÿF ÷‚| cÚ¬˛© √∑D
√Vo_ ƒVF¬Ô°D, ÷Às>D x©√m xÁ≈ ÿƒFB¬ ÔÕ>ÔD ∑›]BVzD. ŒÀÿkVÚ 
xÁ≈•D A]B √VÁÈºB c√ºBV˛¬Ô°D. 
 
  √VK¬z √]_ kVÁw¬Ô‚Á¶ ¿ˆ_ ÔÕ]ÁB √›mxÁ≈ cÚ¬˛ ƒVF¬Ô  ∑›]BVzD.
 ÷D xÁ≈BV_ ÔÕ>Ô›]_ c^· ®ıÿF ¿∫zD ®[√Ï. 
 
 ÿÂ_o¬ÔVF ÔÕ>ÔD √ÈD 5 ÷>Á™ #^ ÿƒFm ÿÔV^·°D ºƒVuÆ¬ Ôu≈VÁwﬂ
ƒVÆ √Ω 1/2, ÿk∫ÔVB ƒVÆ √Ω 1/2, º\u√Ω ƒVu§_ ÔÕ>Ô›Á> ˛aÔ‚Ω ÿ>V∫Ô    
s‚| ƒVÿ≈_ÈVD ∑ı|˛≈ kÁ´l_ ÿ\mkVÔ yÿBˆ›m g≈s‚| ®|›m            
ÿÔV^·°D.  
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 ÷Às>D ÿƒFB©√‚¶ #FÁ\BV™m Ák›]BD kV>ÿ\[–D  
÷ÚxÁ≈Ô”¬zD gzD3. 
 ®ÚÁ\©√Vo_ ÔÕ>Ô›Á> ˛aÔ‚Ω ÿ>V∫Ôs‚| ÔVFﬂE ®|›m  
ÿÔV^·ÈVD. zÁ≈Õ>m 5 >¶Ák x>_ 20 xÁ≈ ÿƒFBÈVD. ÷m  
ÿ√ÚD√VKD \ÚÕ]uz E≈©√V™m gzD.  
 º>ÁkBV™ ÔÕ>Ô›Á> ®|›m ŒÚ ÷ÚDA¬ Ô´ıΩl_ º√V‚| cÚ¬˛   ÁÔBVÕ>
ÔÁ´ ƒVu§_ ªu§ ∑Ú¬z ÿÔV|¬Ô ∑›]BVzD  
 ÿ√V[™V∫ÔıË ƒVuÁ≈ ƒ‚Ωlo¶°D. ÔÕ>Ô›Á> ∂]_ º√V‚| EÆ  yBVÔ      
®ˆ›m  ®|›m Ôøs¬ ÿÔV^·°D.  
 ØıÁ¶ ÂVÏ›>∫ÔVB·°¬z ∂Á´›> Â|s_ ÔÕ>Ô›Á> Ák›m  3 3/4 ÂVaÁÔ 
ºkÔ Ák›m ®|¬Ô ÿk”Á\BVzD. ÿk”Á\   º√VÔVs‚¶V_   ÷´ı¶Vkm      
xÁ≈ Ák¬Ô°D.  
 
ÔÕ>Ô Âﬁ∑ z§zD:15 
 
÷m   ÿÔVΩB   Âﬂ∑›   >[Á\   cÁ¶Bm   ∂[Æ,   #FÁ\ ÿƒF•D xÁ≈lKD 
ÿƒFxÁ≈ÁB ƒˆk´ ÿƒFBV>>VKD ÂV‚√‚¶ ÔVÈ›]_ ÂﬁÁƒ  cı¶V¬zD.  
 
1.   ÔıÔ^ \ﬁƒ^ W≈\VÔ°D, xÔD ÿk”›mD,  c¶DA ÂπÏ z[§ ¨Ï¬ÔDØ º√V[≈    
     W≈›Á>BÁ¶ÕmD ÷Ú¬zD.  
2.  √uÔ^ ÔÆ›m √VEBÁ¶Õm sÔV´©√‚| ÷Ú¬zD.  
3. ÷Á¶s¶V\_ sBÏÁk cı¶VzD. ∂m \ﬁƒ^ W≈D º√V[ÆD,  ºƒuÆ ¿Á´ 
     º√V[ÆD ÷Ú¬zD.  
4. EÆ¿Ï ÿk^·V‚| ¿Á´© º√V[Æ ÷Ú¬zD.  
5. \ÈD ƒV\Õ] ØÁk º√V[Æ \ﬁƒ^ W≈\VlÚ¬zD.  
6. kVl_ AÁÔ ÂVu≈D, klÆ ko, sBÏ¬zÚ º√V[≈Ák cı¶VzD.  
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x§° :  
1.  1. gkV´DºkÏ, 2. Á>ºkÁ· ºkÏ, 3. ¿oºkÏ, 4. ∑¬z, 5. √Ú›]lÁÈ, 6. EÆÂVÔ©Ø
    g˛BkuÁ≈ zΩ¿ˆ‚| zΩ¬Ô Âﬁ∑ yÚD.  
2. t·z, ¿oºkÏ, Ê´ÔD ÷kuÁ≈ ƒˆÿBÁ¶ ®|›m zΩ¿ˆ‚|¬ ÿÔV|¬Ô Âﬁ∑ x§•D.  
3. >V\Á´s›Á> ÷·¿ˆ_ ∂Á´›mı yÚD.  
 
ÔÕ>ÔD ºƒÚD \ÚÕmÔ^10  
 
1. ÿÂ_o¬ÔVF ÿÔÕ] √u√D10 
 
ÿÂ_o¬ÔVF ÿÔÕ>ÔD á 1 √ÈD  
∂Á´ˇÁ´ﬂƒVÆ á ƒ\D  
 
 ÿÂ_o¬ÔVF ÿÔÕ>Ô›]Á™ ∑›] ÿƒFm ∂>uz ∂Á´ˇÁ´ ƒVu§Á™         ºƒÏ›m
 ∂Á´›]¶ √u√\VzD.  
 
 ∂·°  : Ôwﬁ∑  ®Á¶  
       1/2 \ı¶ÈD 
 yÚD  ºÂVF  : zi¶D  
 
2. ƒÔÈ sBV]¬zD ÿÔÕ]  Ô√V¶¬zπÁÔ 10 
ÿÔÕ>D á 1 Ôwﬁ∑  
ÿÂ_o√Ú©A     ÂV∏  
∑¬z      Ô|¬ÔVF  
t·z      ÿk∫ÔV´D  
]©∏o     Û>D  
>V[§     ∂ˆ>V´D  
 
   kÁÔ¬z á 1 Ôwﬁ∑  
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ÿƒFxÁ≈  
 ÿÔÕ>Ô›]Á™ ÿ√VΩ›m Ô_k›]_ ÷‚| \u≈ ƒ´¬zÔÁ·•D ÿ√VΩ›m  
ºƒÏ›m ÔˆƒVÁÈ ƒVu§_ ∂Á´›m √BÆ º√V_ cÚ‚¶°D.  
y ÚD ºÂVF á º\ÔD yÚD  
 
3. ÿÔ·ˆ EÕ>V\Ë  
  Ák›]B ÔVsBD á 1500 
 
ºƒÚD \ÚÕmÔ^ : 
 
 ∑›] ÿƒF> ÷´ƒD  á 30˛  
 ∑›] ÿƒF> ÔÕ>ÔD  á 30˛  
 ÿ√Vˆ›> ÿk∫ÔV´D á 20˛  
 
ÿƒFxÁ≈ :  
 
 ÔÕ>Ô›Á> Ô_k›]o‚| ∂Á´›m¬ ÿÔV^·°D.  ∏≈z ÷´ƒ›Á>ﬂ E§m 
E§>VÔ ºƒÏ›m ®_ÈV \ÚÕmD ÔÆ©√VzD kÁ´ ∂Á´›m ÿ√Vˆ›> ÿk∫ÔV´›Á> ºƒÏ›m
 ∂Á´›m ÿÔ‚ΩBV™ mËl_ √V¬Ô·° cÚıÁ¶BV™ J‚Á¶Ô^Ô‚Ω 
ÊÁÈ ÿƒFm, \ı ƒ‚Ωl_ √´©∏•^· \K¬z^ kˆÁƒBVÔ Ák›m A¶t‚| 
®|›m , g§B ∏[ º\_ ÔkƒD ¿¬˛ \ÚÕÁ> ®|›m Â[z ∂Á´›m Ák¬Ô°D.  
∂·°  : 100 á 200 t_o ˛´VD  
  2 ºkÁ·  
  40 ÂV^  
∂–√V™D  : º>[  
  ]ˆ Ô|z Û´D  
 
y ÚD  ºÂVF  : gkVÁ´¬ za› Á>È›]_ ÿÔV|¬Ô  
  ƒÁ>BÁ¶©A á 18  
  ¿ˆa° á 18,  
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  J›]´©∏´Á· á 21  
  J›]´ ∂Á¶©A  yÚD   
 
 
4. ÿÔÕ] ÿ\øz8 
 
º>ÁkBV™ \ÚÕmÔ^:  
 ∑›] ÿƒF> ÔÕ>ÔD   á 150 ˛  
 ÿk^Á· ÿk∫ÔVBƒVÆ  á 300 ˛  
 ÷ﬁE ƒVÆ    á 300 ˛  
 
ÿƒFxÁ≈ :  
 
 ÔÕ>Ô›Á> Ô_k›]o‚| ÿk^Á· ÿk∫ÔVBﬂ ƒVu≈V_ 5 ÂV‚Ô”D. ÷ﬁEƒVu≈V
_ 5 ÂV‚Ô”D ∂Á´›m ÿ\øz √>›]_ ®|›m¬ A‚Ωl_ √›]´©√|›>°D.  
∂·°  : 200á500 t˛  
∂–√V™D  : √V_, 2 ºkÁ·  
yÚD ºÂVF : ÿkz J›]´D º√V[≈  
    º\Ô¿Ï ºÂVFÔ^, ÿƒV§, E≈∫z,  
    zi¶D, JÈD g˛B™  
 
5. ÔÕ>Ô √u√D 2  
ÔVÕ>Ô›]uz ÿk^Á· ÔV‚¶V\¬z √V_s‚| ŒÚ ƒV\D ∑Ú¬z  
ÿÔV|›m ∏≈z ÷´ı| ÂV^ º\u√Ω √V_ s‚| ∂Á´›m s_ÁÈ >‚Ω cBÏ›],  
E_o‚| 5 k´‚Ωl_ A¶t¶ √u√D gzD. 
∂·°  : 130 á 260 t.˛. 
yÚD ºÂVF  : º>Vu∏ËÔ^. 
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6. ÔÕ>Ô ÿƒÕm´D2 
  
"" º>s•´Õ EkÁ> >ø>VÁwl™V_ EÕ#´\VzD''  
®[≈ º>´[ Ôˆƒ_ ∂ΩBV_  
 
   ÔÕ>Ô›Á> EkÁ> >ø>VÁwl™V_ ÿƒÕ#´\V¬ÔÈVD. 
 
7. ÔÕ>Ô \V›]Á´2 
 
ÔÕ>ÔD, ÂV∏, t·z, Û>D, ØƒÁs›m ÷ÁkÔÁ· ƒ\ÿ™Á¶ ®|›m  
√wﬂƒVu≈V_ ∂Á´›m \V›]Á´ cÚ‚Ω Wwo_ cÈÏ›>°D 
∂·°  : √ﬂÁƒ√B≈·° 
yÚD ºÂVF    : ∑´D. 
 
8. ÔÕ>Ô k¶ÔD2 
 
ÔÕ>ÔD, Ê´ÔD,t·z, ]©∏o, Ô|¬ÔVF, ÂV∏ ÷ÁkÔÁ· ƒ\[ÿ™Á¶  
c|›m ÿkı ÿƒDÁ√lÁÈ ƒVÆ, gÁ´lÁÈ ƒVÆ ÷ku≈V_ >M›>MºB  
∂Á´›m z[§B·° \V›]Á´ ÿƒFB°D. 
 
yÚD ºÂVF : ƒBD, √Vı| 
 
9. ÔÕ>Ô ]´VkÔD12 
 
ÔÕ] 20 √ÈD, mÚ∑ √›m √ÈD, ƒV´D 5 √ÈD, Ê™D 15 √ÈD,  ƒ°‚|©A  
÷Ú√›Á>Õm √ÈD, ÿkΩB©A 20 √ÈD, T´D 4 √ÈD, ÂV•Ús c©A 4 √ÈD  
®^”©A 4 √ÈD gÔ 107 √È∫ÿÔVı¶ ÷ﬂƒ´¬zÔÁ· ÿ√VΩ© √ıË ºÈVÔ  
]´kÔ›Á> kVÏ›m ˛ıΩ >M A‚Ωl_ ∂Á¶›m ÿÔV^·°D. 
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10. ÔÕ>Ô ®ıÿF13 
 
 ÿÂ_o¬ÔVF ÔÕ>ÔD 15 ˛, ÿku§ÁÈ 150 ˛,  ÷Às´ıÁ¶•D  Ô_k›]o‚|      
Œ[≈VÔ ºƒÏ›m ∂Á´›m ÿ\øz √>\V™ c¶[ ŒÚ ]ˆBVÔ cÚ‚Ω ŒÚ ÷ÚDA ƒÈVÁÔ
l_ ∑u§ ∂>[º\_ WÁ≈B √ﬁÁƒ ∑u§ s¶°D.  ∏≈z ÷>Á™ Ô|z ®ıÿl_       
Â[≈VÔ ÂÁ™›m ŒÚ ∑kˆ_ ŒÚ mËÁB AÁ>›m zÆ¬z kƒ\VÔ WuzD√Ω ÿƒFm    
∂>uz ƒˆBVÔ ˇºw ŒÚ ¨∫ÔV[ √V›]´D Ák›m√ﬁE_ ÿÂÚ©∏‚¶V_ ÔÕ>Ô ]´kVÔD  
÷≈∫zD.  ÷>Á™ ®|›m ŒÚ ÊƒVs_ √›]´©√|›>°D.∂kEB\V™V_ \¶¬˛ ÷´ı|    
>¶Ák  ÿƒFm ÿÔV^·°D. 
 
∂·°   á  1á3 mπ 
yÚD ºÂVF : ƒÚ\›Á> √u§™ ∂Á™›m ºÂVFÔ^. 
 
11. ÔÕ>Ô Ô‚|3 
 
 #FÁ\ ÿƒF> ÿÂ_o¬ÔVF ÔÂ>ÔD 1 √ÈD,  \Ú^ ª\›Á> ƒxÈ ƒVÆ,  
\Ë›>¬ÔVπ ƒVÆ,  ÷ÁkÔÁ· kÁÔ Œ[Æ¬z º>ÁkBV™ ∂·°. 
 
 \Ú^ ª\›Á> ƒVuÁ≈ ŒÚ √V›]´›]_ s‚| ∂>[ kVF¬z ºk|Ô‚Ω  
∂>[ *m ÔÕ>Ô›Á> #^ ÿƒFm Ák›m \ı ÔÈ›>V_ JΩ x[ Ôı¶√Ω 
Ø©A¶D ÷¶°D .  ƒV≈V™m ÔÕ>Ô›]uz 5 √∫z ®Á¶ ÷Ú¬Ô ºkı|D.  zπ´ 
g§™ ∏[A ÔÕ>Ô›Á> ®|›m ÿ√VΩ›m x[ ƒVu§_ A¶D ÷¶°D.  ÷Às>D  
\¶¬˛ \¶¬˛ ÂV[z >¶Ák ÿƒF> ∏[, \Ë› >¬ÔVπ ƒVu§KD ÷mº√V_  
ÿƒFB Ô‚|D. 
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CHEMICAL ASPECT 
 
HISTORICAL 
 
 Sulphur was known to the ancients probably due to its frequent occurrence in free 
state. The bible refers to it as brimstone (burning stone). The name Sulphur is derived 
from the Sanskrit word “sulveti” through the Latin word sulphuricam. 
 
Assyrian texts dated around 700-600 BC refer to it as the “Product of the 
riverside”.  
 
Sulphur is non-metallic elements atomic number 16 group NAI of periodic system 
 
¾ Atomic wt-32.06 
¾ Valancies 2,4,6 
¾ Four stable isotopes was present 
 
PROPERTIES: 
 
 Pure Sulphur exist in two stable crystalline forms 
a. Alpha Sulphur 
b. Beta Sulphur 
and two amorphous forms. 
 
ALPHA SULPHUR 
 
 Rhombic, octahedral yellow crystals stable at room temperature. 
 Sp. Gravity – 2.06 
 transition to beta form 94.5o c refraction index – 1.957 
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BETA – SULPHUR 
 
 Monoclinic, Prismatic Pale yellow crystals slowly changing to alpha form below 
94.5o c. 
 Sp. gravity 1.96m.p 119°C 
 Both forms are insoluble in water, slightly soluble in alcohol and ether. Soluble in 
carbon disulfide, carbon tetra chloride and benzene. Both are nontoxic. 
 
EXTRACTION AND PURIFICATION 
 
 Sulphur mixed with clay limestone, and other rock impurities occurs on the 
surface. The Sulphur contained above still contains about 5% of earthly impurities. 
 
 It is used as such or purified by distillation if needed. Crude sulphur is melted and 
than distilled in large iron retorts connected to a brick chamber. At first when the walls 
are cold sulphur vapours condense on the walls to a fine powder called flowers of sulphur 
and may be removed. 
 
 Later on as brick work heats upto above 120o c the condensate remains and 
collects on the floor of chamber. This liquid is tapped and poured in cylindrical moulds 
where it solidifies to give roll Sulphur. 
 
II. FRASCH PROCESS:- 
 
This is an process since it means that Sulphur can be extracted from under ground 
without mining it. In this process under ground deposits of Sulphur are forced to the 
surface using super heated water steam (160R c, 16 atmospheres to melt the Sulphur) and 
compressed air (25 atmospheres). This gives molten Sulphur which is allowed to cool in 
large basins. Purity can reach 99.5%. 
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III. In lab Sulphur can be purified by recrystallisation from solutions in carbon  
      disulphide. 
 
IV.  Another way to purify Sulphur is to use a quartz heater (700OC) immerser. In  
       liquid Sulphur carbon impurities decompose to form a volatile materials of     
       solid carbon which coat the heater. 
 
Combination with elements 
 
 It is active as oxygen and combines with a number of elements metals and non-
metals. 
 
a. With Carbon it combines when Sulphur vapours are passed over red hot coke. 
C+2S   CS2  
 
b. With hydrogen and Chlorine it combines when the gases are passed through 
boiling sulphur. 
S+H2  H2 S 
2S +Cl2      S2 CL2 
 
c. With most of the metals such as copper, iron, mercury, Zinc it combines on 
heating  
Fe +S  FeS 
 Here it acts as on oxidizing agent and oxidizes iron to iron sulphide (FeS) 
 
d. Reducing action 
 
It reduces not concentrated sulphuric and nitric acids. 
e. Reaction of Sulphur with acids 
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Sulphur does not react with dilute non-oxidizing acids 
 
f. Reaction of Sulphur with Bases 
 
Sulphur reacts with hot aqueous potassium hydroxide, KOH, to form 
sulphide and thiosulphate species. 
 
WITH ALKALIS 
 
 Sulphur dissolves in alkalis on heating to give sulphide and thiosulphates. The 
interaction is rather complete and is followed by solution in the sodium sulphide to form 
sodium pentasulphide 
 
WITH OXIDISING AGENTS: 
 
 Sulphur forms explosive mixtures with oxidizing agents e.g., Potassium nitrate.  
 
EFFECT OF HEAT ON SULPHUR  
 
 Ordinary sulphur melts on heating at 114.5° to a pale yellow mobile liquid on 
heating further instead of becoming more mobile as liquids usually do, it grows thicker 
and viscous. At the same time the colour changes form a light yellow to reddish brown 
and then to almost black. At about 180° the mass becomes so viscous that it cannot be 
poured out by inverting the test tube.  
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Molecular structure of Sulphur :  
 
 X ray studies have revealed that the unit present in rhombic sulphur at room 
temperature is the 58 Molecule which forms a puckered 8 membered ring. Probably the 
same unit is present in the monoclinic sulphur also.  
 
BIOLOGICAL INFORMATION 
 
  Sulphur is essential to life. It is a minor constitute of fats, body fluids, and skeletal. 
Sulphur is a key component in most proteins since it is contained in the amino acids 
methionine and cysteine. Sulphur – Sulphur inter actions are important in determining 
protein tertiary structure. Hydrogen sulphide replaces H2O in the photosynthesis of some 
bacteria. 
 
HAZARDS AND RISKS 
 
 Elemental sulphur is relatively harmless but is very toxic to many bacteria and 
fungi. Hydrogen sulphide in very small quantity can be metabolized but in higher 
concentration it can cause death quickly by respiratory paralysis. 
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BOTANICAL ASPECT 
Feronia elephantum corra 
 
 Family : Rutaceae 
 Tamil : Vila 
 English : Elephant or wood apple.  
 Sanskrit : Kapitha 
 Guj : Kotha 
 Bengali : Kathbel 
 Tel : Velaga 
 Malayalam : Vila vilatti 
 Mah : Kavitpana, Kavath 
 
Habitat :   Throughout India; cultivated for its fruits. 
Bot. Description :    Small deciduous tree with short erect, cylindrical stem, 30 
  feet height and 2-4 feet in girth bearing thorny branches 
Leaves  : Leaves pinnate, 3-4 inch long with small ovates or obovate 
leaflets. 
Flowers : Polygamous in lax panicles. 
Fruit : Large, globose or oblate 1.0 – 2.5 inches in diameter hard rough 
woody pericarp seeds numerous, small compressed, embedded in 
a sweetish, aromatic, edible pulp.  
 
Constituents : 
 Pulp contains a large quantity of  
 Citric acid 
 Mucilage 
 Ash containing  
  Potash, lime and iron 
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ANALYSIS OF EDIBLE PART33 
 
Moisture - 69.5 
Protein - 7.3 
Ether ext - 0.6 
Mineral matter - 1.9 
Fiber -  5.2 
Carbohydrate - 15.5 
Calcium - 0.13 
Phosphorus  - 0.11% 
Iron - 0.6mg/100g 
Riboflavin - 170mg/100g 
Vitamin C - 2.0mg/100g 
 
The fruit is rich in calcium & phosphorus 
 
FERONIA GUM33 
 
 From the trunk and branches of the tree exudes a gum resembling gumarabic in 
properties. The exudation is profuse after the rainy season. It is considered to be a good 
substitute for gum Arabic and commercial samples of the latter often contain feronia gum 
in admixture. Feronia gum occurs is irregular, semi transparent tears varying in colour 
from reddish brown to pale yellow or colourless. 
 The gum contains 
  Water  12-17% 
  Ash  4-5% 
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On hydrolysis it yields. 
 
  Pentoses  35.5% 
  Arabinose 
  Xylose 
  D.galactose  42.7% 
 
& traces of Rhamnose & glucuronic acid 
 
From the graded hydrolysis of the gum an aldobiouronic acid                                      [3-
(glucuronopyranosyl – d- galactopyranose )] has been separated. 
 
 The wood is yellowish grey to greyish white, hard and heavy. 
 
CHEMICAL CONSTITUENTS39 
HEART WOOD:  
 
 Ursolic acid – a new Flavanone glycoside 7-0-methylporiol 4-B-D- xylopyranosyl 
glucopyranoside isolated from heart wood. 
 
ROOT BARK:  
 
 Aurapten 
 Bergapten 
 Isopimpinellin 
 6- Methoxy – 7- geranyloxyloumarin 
 Mermerin 
 isolated from root bark  
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SEED AND FRUIT: 
 
 Oil – 34% 
 Protein – 28% 
Oil composed of palmitic (15.2) 
Lino lenic (20.4) and linolic acids – 20.6% 
Besides traces of palmitic and stearic acid. 
β- Sitosterol, β- amyrin, lupeol & stigmasterol from unsaponifiable matter of seed oil. 
¾ Psoralin, bergapten, orientin, vitexin and saponin isolated from leaves 
¾ Metthylchavicol and 1,4 - dimethoxy – 2 – acyl benzene identified in essential oil. 
¾ Roots yielded geranyl umbelliferone bergaptin, osthol, isopimpinellin. 
Xanthotoxin, marmerin and mermin. 
 
ACTION:  
 
Fruit - Aromatic,  
  Antiscorbutic, 
    Astringent 
  Refrigerant. 
Gum - demulcent 
Leaves - aromatic 
  Carminative 
  Astringent 
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Uses: 
 
 Pulp of the ripe fruits, useful in salivation, sorethroat and other affections of gums 
& throat. Transparent gum exuding from the stem may be used in bowel affections and to 
relieve tenesmus. 
 
 The gum is powdered and mixed with honey it is given in dysentery and diarrhoea 
 Syrup of fruit dose – ¼ - 1/2 tp useful in dyspepsia, in quenching the thirst of 
fevers 
 Pulp with honey and pipli is given for hiccup and difficulty of breathing 
 Under  the  name of pancha kapitha, ie five products of Feronia a medicine is 
prepared which contains flowers, roots, leaves, bark and fruit. 
 
s·V  
ºkÆ ÿ√BÏ: 
 
 "" s·Vs–¶D º√Ï>Á™ºB sÚD∏ ºÔ” 
  \Ú¬ÔV™ ÔΩº> >Õ> y>Õm kV|Õ 
   m·Vs–¶ ˛≈˛√È ∑ÔÕ>\Vzﬁ 
  Û>V™ s¶ÔVƒ xuÔ√È \VzÕ 
   ]·Vs–¶ E≈√V˛ ÔΩ©∏ˆBVÔﬁ 
  Ê´V™ ∑kVƒ™Vƒ º√V¬˛ 
   s·Vs–¶ kVƒM>VÔ ÂVƒMBVD 
  kzÕmÁ´›> ÂV\ÿ\_ÈVD s·Vs[ º√º´""  
       á  º√VÔÏ WÔı|  
 
 ÔΩº> >Õ>D, >Õ>D,  y>Õm, ÷≈¬√È∑ÔÕ>D, s¶ÔVƒD, xuÔ√ÈD, ƒu√V˛, ÔΩ©∏
ˆBV, ∑kVƒ™Vƒ º√V¬˛, kVƒM, >VÔÂVƒM. 
ÔΩ©√ÁÔ, Ô∏›>D,  s·°, ÿk^π_ g˛BÁk•D s·Vs[ ºkÆ  
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ÿ√BÏÔ·VD. 
 
k·ˆ¶D: 
 ÷Õ]BV xu§KD √l´VzD 
 
√B[√|D cÆ©A 
 ÷ÁÈ, ÔVF, √wD, √w›][ Œ|, √‚Á¶, ∏E[. 
 
∑Ák  : mkÏ©A  sÆsÆ©A 
>[Á\ : ÿk©√D 
∏ˆ°  : ÔVÏ©A 
 
ÿƒFÁÔ 
  \J©Ω  - Aromatic 
  ∂Ô‚| kVFkÔu§ á Carminative 
  mkÏ©∏  á Astringent 
 
ÔVF 
∑Ák  : mkÏ©A, >[Á\ á >‚√D, ∏ˆ° á ÷M©A 
ÿƒFÁÔ : mkÏ©∏ á Astringent 
zD  : ÷>™V_ Ôaﬂƒ_ kÁÔÔ^ º√VzD. 
 
√wD 
∑Ák  : ÷M©A, >[Á\ á >‚√D,  ∏ˆ° á ÷M©A 
ÿƒFÁÔ : \J‚Ω  á Aromatic  
   zπÏﬂE•ı¶V¬˛   á Refrigerant 
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zD  :  
 
 ""∂©º√VmD ÿ\FÔˇ>\VD ~Á·lÚ \_Ô√x  
   ÿk©√VÚÕ >VÔxD º√VD ÿ\F©√EBVD á ÷©Asl_  
   ®[≈V˛ K∫ÔMº\_ ÷ﬂÁƒÁk›m› ]™ ÿkıË›  
   ][≈V_ s·V∫ÔMÁB ][''  
 
÷‡m ~Á·, ÷Ú\_, ºÔVÁw, ÿk‚√›>VKı¶V™ ¿Ïºk‚ÁÔ ÷ÁkÔÁ·©  
º√V¬zD. ∂[§•D √EÁB cı¶V¬zD. c¶uz Â[Á\ ÿƒF•D.  
 
∏E[  
 
"" Â_È s·VD∏EÁ™ Âu√VÔﬁ ÿƒF>ÚÕ>›  
  ÿ>V_ÁÈB] ƒV´Õ ÿ>VÁÈk]>V[º≈V á ÿ\_oB>VF  
   kÕ>ÿk^Á· >[–¶ºB \V>Ï ÿ√ÚD√V|D  
    cÕm ¿Ï© º√V¬zº√VD cı.''  
 
#FÁ\BV™ s·VD∏EÁ™© ÿ√VΩ›m \V›]Á´ x>oB \ÚÕmÔ^ ÿƒFm cı¶
V_ ¿Ω›> Ôaﬂƒ_, ÿk^Á·, ÿ√ÚD√V|, ¿ˆa° g˛B ÷Ák ¿∫zD.  
 
kw¬z:  
 ÷>Á™© √Vı|, ÔV\VÁÈ, ºƒVÁ√ g˛B ºÂVFÔ”¬zﬂ ÿƒF•D  
÷ºÈ˛B∫Ôπu ºƒÏ¬ÔÈVD. (º√VÔÏ á 700)  
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ºƒÚD \ÚÕmÔ^  
1. ∂]∏¶B¬ zΩ¿Ï25  
ºƒÚD ƒ´¬zÔ^:  
 
ºÔVÁ´ ˛w∫z, ÿ√Ú\´©√‚Á¶, ]´V‚Áƒ, ÷ÈkD ∏E[, \VD√‚Á¶,  
ÂVk_√‚Á¶, g|][™V√VÁ·, ÷K©Á√Ø, ÿÔV›>V[, s´‚∑ıΩ, s_k© ∏ﬁ∑∂›]©
∏ﬁ∑, s·VD∏E[, ÿk‚√VÁÈºkÏ, ƒÕ>™D.  
 
yÚD ºÂVF  :   ]ˆº>V¶D, ®KDAÚ¬˛ yÚD.  
 
2. ®KDAÚ¬˛ , ¿ÏÔ|©A,  Ô_ÈÁ¶©A¬z 25 
 
m›]ºkÏ√‚Á¶, Â›Á>ﬂÛˆ ºkÏ©√‚Á¶, ∑¬z, EÆˇÁ´ºkÏ, gkVÁ´ 
sÁ>, ºkÈD∏E[ , ƒ>z©Á√, gkVÁ´ºkÏ√‚Á¶, ∂_o¬˛w∫z, s·VD∏E[  
     kÁÔ¬z á 2 Ôwﬁ∑  
√∑s[º\VÏ, ®ÚÁ\º\VÏ, √∑s[ >lÏ,  ÷ÁkÔπ_ ∂Á´›m¬ ÔÈ¬˛BÚÕ>°D.  
 
yÚD ºÂVF  :   ¿Ï√VÁ· yÚD  
 
3. ÈzÔ‚|kV∫Ô \V›]Á´ 14 
  
ÿÔVΩzÆﬁƒVlÁÈ #^    á 4 s´V 
s·VD∏E[    á 20 s´V 
∂∏M    á 1/2 s´V  
 
∂Á´›m 5 \V›]Á´Ô·V¬˛ ŒÚ \V›]Á´ ÿÔV|›mk´ º√], Ê>º√],  
÷Ú\_, Ô¬zkV[ ∂]ƒV´ º√] z\VzD.  
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4. o∫Ôº√] \V›]Á´ : 14 
 Ô‚Ω™o∫ÔD, ∞ÈD, ƒı√Ô©Ø, Ô|zº´V˛Ë, ºÔVi¶D á  3 s´V 
 
∑›]›> ºÂÏkV· √Ú©A á 15 s´V  
 s·VD∏E[ ºƒÏ›m ∂Á´›m z[§\Ë ∂·kVÔ \V›]Á´ ÿƒFB°D.  
∂·°  :  1 \V›]Á´  
      ÿƒÀÁkBVÔ º√]BVzD  
5. ÔV¬Ô™V[ ºkÏ \V›]Á´ 14 
 
ÿk^Á·ÔV¬ÔV[ ºkÏ, ]©∏o á 2 s´V  
∑¬z. t·z  á 3 s´V  
s·VD∏E[ á 2 s´V  
z[§\Ë ∂·° \V›]Á´  
∂·°  :  1 \V›]Á´ á º√]BVzD  
 
6. ÿ√ÚD√V|, ®KDAÚ¬˛, \mº\ÔD, ¿ˆa°,  sBV]¬z ÿÂF6  
 
ÂVk_√‚Á¶ 25 √È›Á> Ô≠VBt‚| 1/2 √Ω √∑s[ ÿÂF ÔÈÕm 
∞È¬ÔVF 
ÔuÔ¶E∫˛ 
ÔVEÔ‚Ω 
Ê´ÔD 
∂]\m´D 
s·VD∏E[ 
÷Èk∫Ô©√‚Á¶ 
ÔV‚¶V›]Ø 
EÆÂVÔØ 
ºÔVi¶D 
÷ÁkÔÁ· kÁÔ¬z 1/2 √ÈD 
∂∏[  á 1 k´VÔ[ 
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 ÷ÁkÔÁ· ÁÂkVBÁ´›m º\uÌ§B ÿÂF ÔÈÕm Ô≠VB›]_ º√V‚|        ÿ\øz
 √>\VF ÔVFﬂE kΩ›m¬ÿÔV^·°D .  ºkÁ· Œ[Æ¬z 2 k´VÔÿ™Á¶      T>D]™D 2 º
kÁ· 1 Ô´ıΩ ÿ√VÚD√V|, ƒÔÈs>\V™ º\Ô∫Ô^ yÚD. 
 
7. «ˆ>˛ ºÈ˛BD:6 
 
ÿÔV‚Á¶√V¬Ô·°. 2 ºkÁ·,  
1 \ı¶ÈD  
yÚD ºÂVF  : ÿ√VÚ\_ Û>ÔkV•, ˛´VË,  
  z[\D, c¶DA, klÆ ÷ku§[ ®ˆ° yÚD. 
 
 
kVÁw 
Musa paradisica linn 
 
ºkÆÿ√BÏ:   
∂D√D, ∂´DÁ\, {Áƒ, Ô>o, ÔkÏ, ºƒ˛o, ]´√]. 
 
kVÁw¿Ï zD: 
 
 "" kVÁw¿Ï Ê>ÿk©A k_È √Èxı¶V¬zD 
   º√Áw klÆÁ¶¬zD ÿ√ı\lºÈ á Tøk_o 
   ´›>¬ ˛ˆﬂƒ ÿ\ˆ¿ˆÁk•¶º™ 
   Eu§´D º√V¬zÕ ÿ>ˆ''  
 
 kVÁw¿´V™m ÿ√ÚklÆ, ÷´›>˛ˆﬂƒ´D, ®ˆJ›]´D, ∂u√s´D,  
ºƒV\º´VÔD, √Vı| g˛BÁkÔÁ· ¿¬zD. 
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MATERIALS AND METHODS 
 
COLLECTION OF THE DRUG 
 
 The sulphur was collected from indigenous drug store the Feronia elephantum 
gum [Vilaam pisin] was collected from a forest near Pollachi. 
 
INGREDIENTS USED  
 
 Gandagam (Sulphur) 
 Vilaam pisin - Feronia elephantum / Limonia gum 
     
PURIFICATION OF SULPHUR 
 Take 500g of sulphur in an iron vessel add some quantity of butter to it and heat 
till the sulphur melts in it. Pour this sulphur in 1 litre quantity of Vazhai kattai fresh juice 
each time. Wash and clean the impurities.  
 
PURIFICATION OF VILAAMPISIN 
 The vilaampisin was washed with fresh water and the impurities were removed. 
 
METHOD OF PREPARATION 
 Sulphur was soaked in vaalai kattai juice (rhizome juice of Musa paradisica) for 5 
days.  After 5 days this sulphur was taken in an earthern vessel and fried in heat till it 
becomes slight white in colour. This sulphur was then put in the kalvam and the 
vilaampisin was added and it was grinded fine using vaalaikattai juice and brought to 
consistency. This was rolled into 130 mg pills and dried in shade. 
 
Dosage: 1 Tablet (130 mg) with water (30ml)  
Route  : Enteral. 
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METHODOLOGY FOR PHYTO CHEMICAL ANALYSIS OF 
GANDHAGA PARPA MATHIRAI 
 
 The drug powder and various extracts of Gandhaga parpa Mathirai were 
subjected to chemical tests for identification of its active constituents. 
 
TEST FOR ALKALOIDS. 
 A small portion of the solvent, free chloroform, alcoholic and aqueous extracts 
were treated separately with few drops of dilute HCL and filtered.  The filter may be 
tested carefully with alkaloidal reagents such as, 
  a. Mayer’s  reagent  – yellow precipitate 
  b. Dragendroff’s reagent  – Orange brown precipitate 
  c. Wager’s reagent   -  Reddish brown precipitate 
 
TEST FOR CARBOHYDRATES 
Molisch’s test: 
 
 Filterate was treated with 2-3 drops of 1 % alcoholic alpha – napthol solution and 
2 ml of concentrated H2SO4 was added along the sides of the test tube.  Appearance of 
brown ring at the junction of 2 liquids show the presence of carbohydrates. 
 
TEST FOR GLYCOSIDES. 
 
 Another portion of  Gandhaga parpa Mathirai  was hydrolysed with HCL for 
few hours on a water bath and the hydrolysate was subjected to Legal’s Bentrager’s test 
to detect the presence of glycosides  
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A.  LEGAL’S TEST 
 
.To the hydrosylate, 1 ml of pyridine and few drops of sodium nitro prusside 
solution were added and then it was made alkaline with sodium hydroxide solution.  
Appearance of pink to red colour shows the presence of glycosides and aglycones. 
 
B. TEST FOR PHYTOSTEROL 
 LIEBERMAN BURCHARD TEST. 
 
 1 gm of the extract of  Gandhaga parpa Mathirai   was dissolved in few drops of 
dry acetic acid 3 ml of acetic anhydride was added followed by few drops of concentrated 
sulphuric acid.  Appearance of bluish green colour shows the presence of phytosterol. 
 
TEST FOR SAPONINS. 
 
 The extracts of  Gandhaga parpa Mathirai  was diluted with  20 ml of distilled 
water and it was agitated on a graduated cylinder for 15 minutes.  The formation of 1 cm 
layer of foam shows the presence of saponins. 
 
TEST FOR TANNINS AND PHENOLIC COMPOUNDS. 
 
 Small quantities of various extracts were taken separately in water and tested for 
the presence of phenolic compounds and tannins by adding dilute ferric chloride solution 
(5%).  The formation of violet colour shows the presence. 
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TEST FOR PROTEINS AND FREE AMINO ACIDS 
 
 Small quantities of various extracts of Gandhaga parpa Mathirai were dissolved 
in a few ml of water and treated with ninhydrin reagent.  Appearance of purple colour 
shows the presence of proteins and free amino acids. 
 
TEST FOR FLAVANOIDS. 
 
 With aqueous sodium hydroxide solution the extract gives blue to violet colour if 
anthocyanins are present, yellow colour if flavones are present yellow, to orange if 
flavones are present. 
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RESULTS OF PHYTOCHEMICAL TESTS OF GANDHAGA PARPA 
MATHIRAI 
 
Sl.No Constituents Gandhaga Parpa Mathirai 
1. Alkaloids + 
2. Carbohydrates - 
3. Glycosides + 
4. Saponins - 
5. Tannins + 
6. Amino acids + 
7. Flavanoids - 
8. Phenol - 
9. Phytosterol + 
10. Protein + 
11. Tannic Acid - 
 
 
INFERENCE:  
  
  The phytochemical tests of the Gandaga Parpa Mathirai showed the presence of 
Alkaloids, Glycosides, Tannins, Amino acids, Phytosterol and Protein.  
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METHODOLOGY FOR ANTI-MICROBIAL STUDY 
 
METHOD: 
 
 The anti-bacterial activities of different extracts of Gandhaga parpa Mathirai 
were studied by disc diffusion method against the following organisms. 
 
1. Streptococcus mutans 
2. Staphylococcus aurens 
3. Escherichia coli 
4. Klebsiella preumoniae 
5. Pseudomonas aereginosa 
6. Candida albicans  
 
Extracts of Gandhaga parpa Mathirai were used in the concentration of 100, 50 
and 25 ml using their respective solvents.  Ciprofloxacin ( 50 mcg / disc ) was used as 
standard. The disc diffusion method was employed for the screening of anti – bacterial 
activity. 
 
DISC DIFFUSION METHOD. 
 
 A suspension of organism was added to sterile soya bean casein digest agar media 
at 45oC, the mixture was transferred to sterile petridishes and were allowed to solidity. 
Sterile discs, 5 mm in diameter, dipped in solutions of different extracts, standard and a 
blank was placed on the surface of agar plates.  The plates were left standing for one hour 
at room temperature as a period of pre incubation diffusion to minimize the effects of 
variation in time between the application of the different solutions.  Then the plates were 
incubated at 37o C for 18 hours and observed for anti-bacterial activity.  The diameter of 
zones of inhibition were observed and measured.  The average area of zones of inhibition 
were calculated and compared with that of standard’s. 
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RESULT FOR ANTI MICROBIAL STUDY OF GANDAGA PARPA 
MATHIRAI  
 
 Organism 
Standard 
drug 
Ciprofloxacin 
50 mcg/disc 
Test drug (GPM µl/disc ) 
Sensitivity Zone of Inhibition in mm 
10µl 25µl 50µl 
Strp. Aureus 31 17 21 24 HS 
Staphylococcus  
epidermidis 
29 14 20 23 HS 
E. Coli 29 30 17 18 HS 
Klebsiella 
pneumoniae 
28 12 16 19 HS 
Pseudomonas 
Aureginosa 
29 15 19 20 HS 
Candida  Albicans 30 16 19 21 HS 
Tricoderma 
Viridian 
31 17 19 22 HS 
 
14 mm – Low sensitive, 15mm – Moderate, above 16mm – highly sensitive  
HS – Highly Sensitive 
 
NOTE :  
SAMPLE CONCENTRATION : -  
  4gm – 400 ml of solvent in 25µl, 50µl, and 100µl/disc  
 
Standard for Bacteria :  
  Ciprofloxacin HCL, 50 mcg/ disc 
 
Standard used for fungus :  
  4.0 gm – 400 ml of solvent  
  10µl, 25µl, 50µl/disc  
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METHODOLOGY FOR BIO – CHEMICAL ANALYSIS. 
 
PREPARATIONS OF EXTRACT 
 
 5gm of  Gandhaga parpa Mathirai   was weighed accurately and placed in a 250 
ml clean baker and added with 50ml of distilled water. Then it was boiled well for about 
10 mins. Then it was cooled and filtered in a 100ml volumetric flask and made upto 
100ml with distilled water. 
 
TEST FOR CALCIUM. 
 
 2ml of extract was taken in a clean test tube. To this 2ml of 4% ammonium 
hydroxide solution was added.  Presence of calcium is denoted by formation of a white 
precipitate. 
 
TEST OF IRON (FERRIC) 
 
 The extract was treated with glacial acetic acid and potassium Ferro cyanide. 
Presence of ferric Iron is denoted by a blue colour  
 
TEST FOR IRON (FERROUS) 
 
 The extract was treated with conc. HNO3 and ammonium thiocyanate. (presence of 
ferrous iron is denoted by formation of blood red colour) 
 
TEST FOR SULPHATE: 
 
 2ml of the extract was added to 5% barium chloride solution. Presence of sulphate 
is denoted by formation of a white precipitate. 
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TEST FOR CHLORIDE: 
 
 The extract was treated with silver nitrate solution. The presence of chloride is 
denoted by formation of a white precipitate. 
 
TEST FOR CARBONATE: 
 
 The extract was treated with concentrated HCL. If carbonate is present, it is 
denoted by effervescence. 
 
TEST FOR PHOSPHATE: 
 
 The extract was treated with ammonium molybdate and conc. HNO3 if phosphate 
is present, it is denoted by the formation of a yellow precipitate. 
 
TEST FOR UNSATURATION: 
 
 1ml of potassium permanganate solution is added to the extract. The presence of 
unsaturation is denoted by decolourisatrion. 
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RESULTS OF BIO – CHEMICAL ANALYSIS 
 
Sl.No Constituents Gandhaga Parpa Mathirai  
1. Calcium  + 
2. Iron  (Ferric)  - 
3. Iron (Ferrous)  + 
4. Sulphate  + 
5. Chloride  + 
6. Carbonate  - 
7. Phosphate  - 
8. Unsaturated  - 
 
The acid radicals present were Chloride and Sulphate  
The Basic radicals Present were Calcium and Iron (ferrous)  
 
 
RESULT FOR QUANTITATIVE ANALYSIS 
 
Sl.No Test Parameters Result 
1 Calcium as Ca  0.21 %  
2. Copper as Cu 20.7 mg/kg 
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PHARMACOLOGICAL STUDY 
 
MATERIALS AND METHODS 
 
Test Drugs 
 
 The following medicinal plant used in the study was collected and processed by 
the methods prescribed in standard text book of siddha medicine. 
 
     Gandhaga Parpa Mathirai was prepared by the method described in   
(Sarabendrar vaidiya ratnavali). 
 
Preparation of drug for dosing 
 
 Gandhaga Parpa Mathirai  used for the study was suspended each time with 1% 
(w/v) solution of sodium carboxy methyl cellulose before administration. 
 
Drugs and chemicals 
 
 Alloxan monohydrate and fine chemicals used in these experiments were obtained 
from Sigma Chemicals company, U.S.A. Other analytical grade chemicals were obtained 
from S.d. Fine Chemicals Ltd., Mumbai. 
 
Experimental animals  
 
 Colony inbred animal strains of swiss albino mice of single sex weighing 20 - 25 g 
were used for the toxicological studies and wistar rats of either sex used for toxicological 
study.  The animals were kept under standard conditions 12:12 (day/night cycles) at 220C 
room temperature, in polypropylene cages. The animals were fed on standard pelleted 
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diet (Hindustan Lever Pvt Ltd., Bangalore) and tap water ad libitum. The animals were 
housed for one week in polypropylene cages prior to the experiments to acclimatize to 
laboratory conditions. The experimental protocol was approved by the Institutional 
Animal Ethical Committee (IAEC). 
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METHODOLOGY FOR ACUTE ORAL TOXICITY STUDY 
 
Acute oral toxicity was conducted as per the OECD guidelines (Organization of 
Economic Cooperation and Development) 423 (Acute Toxic Class Method). The acute 
toxic class method is a stepwise procedure with 3 animals of a single sex per step. 
Depending on the mortality and /or moribund status of the animals, on the average 2-4 
steps may be necessary to allow judgment on the acute toxicity of the test substance. This 
procedure results in the use of a minimal number of animals while allowing for 
acceptable data based scientific conclusion. 
 
The method uses defined doses (5, 50, 300, 2000 mg/kg body weight) and the 
results allow a substance to be ranked and classified according to the Globally 
Harmonized System (GHS) for the classification of chemicals which cause acute toxicity 
 
EXPERIMENTAL PROCEDURE  
 
 Swiss albino mice of single sex weighing 20- 25g were used for the study. The 
starting dose level of Gandhaga parpa Mathirai  was 2000 mg/kg body weight (per 
oral). As most of the crude extracts posses LD 50 Value more than 2000 mg/kg P.O, the 
starting dose used was 2000 mg/kg P.O. Dose volume was administered 0.1ml/10 gm 
body weight to the mice which were fasted over night. With water ad libitum Food was 
withheld for a further 3 to 4 hours after administration and observed for signs of toxicity. 
Body weight of the mice before and after administration. Were noted and an changes in 
skin and fur, eyes and mucous membranes and also respiratory, circulatory,. Autonomic 
and central nervous systems and somatomotor activity  and behavior pattern. Were 
observed, and also signs of tremors, convulsion, salivation, diarrhoea, lethargy, sleep and 
coma were noted. The onset of toxicity and signs of toxicity were also noted.  
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RESULTS FOR ACUTE ORAL TOXICITY STUDY 
 
 
Gandhaga Parpa Mathirai at the dose of 2000mg/kg/po did not exhibit any 
mortality in mice. As per OECD 423 guidelines the dose is said to be “Unclassified” 
under the toxicity scale. Hence further study with higher doses was not executed.  
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METHODOLOGY FOR ANALGESIC AND ANTIINFLAMMATORY 
STUDIES 
Analgesic activity   
Tail Flick method 
 Withdrawal of tail (Tail Flick) for noxious thermal (radiant heat) can be used 
for screening drugs with analgesic activity. Radiant heat can be generated by passing 
electrical current through nichrome wire mounted in an analgesiometer. 
 The base of the tail of the test rats is placed on a nicrome wire. The tail 
withdrawal for the radiant heat (flicking response) is taken as the end point. Normally the 
rats and mice withdraw their tails within 3 – 5 secs. A cutoff time of 10 – 12 secs is used 
to prevent damage to the tail. Any animal failing to withdraw its tail in 3-5 secs is 
rejected from the study.  
 The reaction time of test drug, standard and control are taken at intervals of 
30, 60 and 120 mts. A reaction time (withdrawal time) increment of 2-5 secs more than 
the control animals can be considered for analgesic activity of the drug.  
Anti inflammatory activity  
 Anti inflammatory activity was evaluated in acute model of inflammation.  
Acute model 
Carrageenan induced hind paw edema  
 The carrageenan assay procedure was carried out according to the method of 
Wintar et al. (1962). Edema was induced by injecting 0.1 ml of 1% solution of 
carrageenan in saline into the plantar aponeurosis of the left hind paw of the rats.  The 
extracts, reference drug and the control vehicle (distilled water) were administered 60 
 115
min prior to the injection of the carrageenan. The volumes of edema of the injected and 
contra lateral paws were measured at +1, 3 and 5 hrs after induction of inflammation 
using a plethysmometer (Bhatt et al., 1977) and percentage of anti-inflammatory activity 
was calculated.   
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RESULTS FOR ANALGESIC AND ANTIINFLAMMATORY 
STUDIES OF GANDHAGA PARPA MATHIRAI 
 
The drug formula Gandhaga Parpa Mathirai  exhibited significant Analgesic 
activity (P<0.001) when compared to control in tail flick method. The analgesic response 
was exhibited only at the end of 60 and 120 mts after drug administration that may be due 
to the delayed absorption of the phytoconstituents responsible for the analgesic activity.  
 
In the acute phase inflammation model (carrageenan induced hind paw edema) 
Gandhaga Parpa Mathirai showed significant (P<0.001) anti-inflammatory activity. In 
this study also the anti-inflammatory response was noticed at the end of 120 mts of 
administration whereas standard drug diclofenac sodium exhibited immediate response. 
This again may be due to the delayed absorption of the phyto constituents present in the 
drug from the intestine.  
 
The analgesic and antiinflammatory activity exhibited by Gandhaga Parpa 
Mathirai have significant correlation with the clinical study reported in the thesis. 
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Analgesic activity of ( Gandhaga Parpa Mathirai ) using Tail flick Method 
 
 
Groups Paw licking response  (Sec) 
 
0 min 
( Sec) 
30 min 
( Sec ) 
60 min 
(Sec ) 
120 min 
(Sec) 
Control 2.386± 0.396 
 
2.293± 0.96 2.36±0.367 2.482± 0.653 
 
GPM 
(500mg/kg. 
p.o.,) 
2.386 ±  
0.116 
ns 
 
2.63 ± 0..328 
ns 
3.38 ± 1.033 
** 
4.16 ± 0.719 
** 
Standard 
(Diclofenac 
Sodium) 
(5mg/kg/po) 
2.266 ±  
0.391 
 
3.53 ±  0.450 
*** 
4.533 ±  0.388 
*** 
 
5.803 ±  
0.7995 
*** 
 
 
n=6,  Values are expressed as mean ± S.D using followed by paired T – test  
**P<0.001 as compared with control.  
ns - Non significant as compared with control     
                                 
Anti inflammatory activity of  Gandhaga Parpa Mathirai induced hind paw edema 
in rats 
 
Groups Paw volume ( ml) by mercury Displacement at regular interval 
of time 
 
0min 30min 60min 120min 240min 15 hrs 
Control 
 
 
1.633± 
5.164 
1.883 ± 
4.472 
2.10 ± 
8.944 
2.23 ± 
0.103 
2.33 ± 
7.528 
2.36 ± 
8.944 
GPM 
(500mg/kg. 
p.o.,) 
1.683 ± 
0.1472  
ns 
1.808 ± 
0.1497 
ns 
2.0 ± 
0.303 
ns 
2.13 ± 
8.944 
*** 
1.92 ± 
8.197 
*** 
1.306 ± 
8.944 
*** 
Standard 
(Dic.Sodium 
5 mg/kg/po) 
0.835 ± 
0.065*** 
1.315 ± 
0.069*** 
1.128 ± 
0.049*** 
1.011 ± 
0.056*** 
0.896 ± 
0.048*** 
0. 85 ± 
0.054 *** 
 
n=6; Values are expressed as mean ± S.D followed by paired T – test. 
ns - Non significant as compared with control; 
P< 0.000 (***) as compared with control. 
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CLINICAL ASSESSMENT 
ABOUT DISEASE AS PER SIDDHA ASPECT 
 
ºkÆÿ√BÏÔ^  : 
 
¾ ÿk^Á· ºÂVF 
¾ ÿk‚Á¶ ºÂVF 
¾ ∏´tBD 
¾ ∏´tBº´VÔD 
 
÷B_ 
 ÊÆWÏ ÷≈∫zk>uz x[º™V (∂)  ∏[º√V ÿkıË≈›m¶[ Êµº√V_  
÷a>_, ¿ÏAÁwl_ ®ˆﬂƒK¶[ Ô|©A cı¶V>ÈV˛B ÷B_AÁ¶B ºÂVBVD. 
 
ºÂVF kÚk>uÔV™ ÔV´∫Ô^. 
 
"" √V¶VÔ ÿ√ı º√VÔD tÔ sÚD∏ √B[§‚| √‚ΩMºB 
     tÔ sÚ›>_ 
>V¶VÔ >[ √V>›]u Û|>V∫Ô_ ƒ´ƒ\VF¬ ÔV´›Á> 
     tÔ AE›>_ 
ª¶VÔ c©AÁ≈©A› mkÏ©A tﬁE_ c¬˛´\VD 
     √È√ÈkVD sºƒ≠D ÿƒF>_ 
ÔV¶V™ \™¬˛ºÈƒ∫ ÔV´\V™ ÁÔ>>ºÈV| tz›>om 
     ÔVb∫ÔVº''. 
1. tÔ ƒDº√VÔD 
2. tzÕ> √‚ΩM 
3. Ô|Á\BV™ ÿklo_ ∂]ÔD Â¶›>_ 
4. √V>∫Ôπ[ Û| 
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5. ÔV´\V™ ÿ√VÚ^ÔÁ·•D á c©A cÁ≈©A, 
     mkÏ©A, ÁÔ©A á ∑Ák•Á¶B ÿ√VÚ^ÔÁ· ∂]ÔD AE›>_. 
6. ÷ÕºÂV•uº≈Vˆ¶D Ì|km 
7. ºBVÔ›]_ WÁÈ›m JÈ¬ Ô™ÁÈ ®ø©ADº√Vm ÷ÕºÂVF ∏≈¬zD 
 
ºÂVF ®ı: 
 "" cÁ´›]‚º¶[ ∏´tB ÿ\[≈ º´VÔÕ>Vº™ 
      c›>\º™ ÷Ú√›ÿ>V[≈Vz∫ Ôı¶VF''  
®™ºk ∏´tBD 21 kÁÔBVzD. 
 
z§z∫Ô^ 
ÔVºk xmÿÔKDA ºÔVÏÁk ∑u§ Ô™\V™ 
   ÂV∏lKD Ô]›mﬂ ∑u§ 
gºk kΩ¬zFB JÈV>V´ \w[Æ tÔ ºÂVkV˛ 
   √u§¬ ÿÔV^”D 
ÂVºk ÂVΩºBV ÿ¶KD∏[ ÛµÕm ÂÈ\V™ 
   ∑º´VË›>]_ tÔﬂ ÔÈÕm 
gºk BΩklÆ ÷ø›m ºÂVkVD gÔV> 
   ∏´tB ›]™V[ Á\V>Vº™ 
1. xmz, ÂV∏ g˛BÁkÔπ_ ko 
2. ∂Ωklu§_ ko 
3. zFB›]_ ∂wuE, ºÂV° g˛BÁkÔ^ ÔVbD. 
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AS PER MODERN CONCEPT 
 
 The word Leucorrhoea is described as  any white or yellowish white discharge 
from the vagina strictly excluding the presence of blood. The pH of the vaginal secretion 
averages about 4.5 during reproductive period the acidity which is undoubtedly oestrogen 
dependent. This acidic PH inhibits the growth of pathogenic organism the lactic acid of 
the healthy vagina  and the vaginal portion of the cervix.  Any vaginal discharge which is 
frankly purulent and contains pus cells and from which the causative organisms can be 
isolated and cultured should be considered as due to a specific vaginal infection. 
 
TRICHOMONIASIS 
 
I. One of the most commonly occurring 
II. Itching in vulva 
III. Disease almost entirely in child bearing era 
IV. By inadequate hygiene & sexually transmitted 
V. By use of an infected persons towels, clothes. 
 
CANDIDIASIS:  
 
 Vulvo vaginitis, monilial  
 Abnormal vaginal discharge associated with vulval irritation  
 
SIGNS & SYMPTOMS  
 
I. Intense vulval itching  
II. Thing curd like vaginal discharge  
III. Dyspareunia at times 
IV. Erythema of Vulva  
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V. Inflammed, vulval skin  
VI. Thick white patches appear attached to vaginal mucosa.  
 
CAUSATIVE ORGANISM 
 Trichomonas vaginalis, a protozoan  
 
SYMPTOMS 
I. Vaginal discharge is profuse thin creamy or slightly green 
II. Irritant and froathy 
III. Pruritis & inflammation of vulva 
IV. Dysuria, frequency of urination and low grade urethritis 
 
NON SPECIFIC VAGINITIS 
 
 Mixed pathogens are recovered. 
 
CAUSATIVE ORGANISM 
 
 Staphylococci 
 Streptococci 
 Ecoli 
 
SYMPTOMS & SIGNS.    
 
1. Irritation, Tender vagina 
2. Burning micturition & dysuria 
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CLASSIFICATION 
1. Non Infective 
I. Physiological excess 
II. Cervical cause 
III. Vaginal cause 
 
2. Infective 
I. Specific 
II. Non – Specific 
 
3. Neoplastic 
4. Foreign body 
 
INCLUDING CRITERIA 
1. White / yellowish discharge per vagina 
2. Vulval irritation 
3. Itching in vulva 
4. Low back pain 
5. Lower abdominal pain  
6. Dysuria  
 
EXCLUDING CRITERIA 
1. Blood  Stained 
2. Pregnancy and lactating mother 
3. Irregular follow up cases 
 
INVESTIGATION PROCEDURES 
 Routine examination were done, diagnosis were made on the basis of signs  and  
symptoms 
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Medical Advice 
I. Advice regarding personal hygiene 
II. Avoidance of synthetic garments 
III. Fingernails should be clipped short 
IV. Avoidance of contamination of vulva 
with ablution of water after bowel action. 
V. Improving general health. 
VI. The partners were also enquired for infection and advised 
for treatment. 
 
 Number of cases taken were 45 in that 40 were subjected for the clinical study and 
the following were observed during the course of treatment. 
 
 Age, socioeconomic status personal habits & diets, occupational status, signs & 
symptoms during admission were recorded.  Improvement showing signs and symptoms 
and statistical analysis after treatment is recorded and tabulated as follows. 
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AGE DISTRIBUTION:  
  
S.No AGE No.of.Cases Percentage  (%) 
1. 11-20 7 17 
2. 21-30 22 55 
3. 31-40 11 27 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INFERENCE  
 Among 40 Patients 7 (17%) were Between 11-20, 22 (55%) were in the age group 
21-30 and 11 (27%) were in the age group 31-40.  
 
 
 
AGE DISTRIBUTION
17%
27%
56%
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z
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OCCUPATION WISE  DISTRIBUTION :  
 
S.No Occupation  No.of.Cases Percentage  (%) 
1. House Wife  28 70 
2. Students 8 20 
3. Tailor  1 2 
4. Daily Labour  3 7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INFERENCE :  
 
 Among 40 Patients 28 (70%) patients were House wife, 8 (20%) patients were 
students 1(2%) was tailor and 3(7%) patients were Daily Labour.  
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 SOCIO- ECONOMIC STATUS
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 SOCIO- ECONOMIC STATUS:  
 
S.No Socio – Economic Status  No.of.Cases Percentage  (%) 
1. Poor  26 65 
2. Moderate  10 25 
3. High 4 10 
 
 
 
 
 
 
INFERENCE :  
Among 40 patients 26(65%) were poor, 10(25%) were moderate class and 4 (10%) 
were high people. This data show s that Leucorrhoea is most prevalent in poor people due 
to poor hygienic conditions.  
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SYMPTOM WISE DISTRIBUTION
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SYMPTOM WISE DISTRIBUTION 
Symptoms 
Before 
Treatment 
After 
Treatment 
Improvement 
Percentage 
(%) 
Yellowish /white 
discharge 
40 8 32 80 
Vulval irritation 30 2 28 73 
Itching in Vulva 33 3 30 90 
Lower Abdominal Pain 35 10 25 71 
Low Back Pain 25 10 15 60 
Dysuria 25 4 21 84 
 
 
 
 
 
 
 
 
 
 
INFERENCE:  
 Patients with the parameters that is Yellowish /white discharge, Vulval Irritation, 
Itching in vulva, Lower abdominal pain , Low back pain ,Dysuria  were taken for the 
study.  
Among 40 patients 32 pts improved from Yellowish/ white discharge 
Among 30 patients with Vulval Irritation 28 got relief from the symptom. 
Among 33 patients with Itching in vulva 30 improved. Among 35 patients with Lower 
abdominal pain 25 got relief, Among 25 Patients with  Low back pain 15 got 
improvement, Among 25 Patients with Dysuria  only 21 got improvement.  
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MARITAL STATUS 
75%
25%
Married Un Married
MARITAL STATUS  
 
S.No Marital Status No.of Patients Percentage (%) 
1. Married 30 75 
2. Un Married 10 25 
 
 
 
 
 
 
INFERENCE :  
 
 Among 40 patients 30 (75%) patients were married and 10 (25%)  patients were  
unmarried. This shows that the disease is more prevalent in the married women.  
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VAGINAL SMEAR 
 
 
S.No. Vaginal Smear No. of  Patients 
BT AT 
1. Trichomonas Vaginalis (TV) 5 3 
2. Candida albicans 4 3 
3. Non – Specific infections 36 30 
 
INFERENCE:  
Among 40 patients 5 patients were found positive for Trichomonas, 4 were found 
positive Candida albicans and 36 were of Non-specific infections. 
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METHODOLOGY FOR STATISTICAL ANALYSIS  
 
To study variation in one or more attributes the data are expressed mostly as 
proportions. If a sample is divided into only two classes such as successes and failures it 
is said to have a binomial  
 
 
   Number of individuals having a Specific Character  
P =   
      Total Number  
   Character in a binomial distribution is expressed   
P =   
      Total Number  
  q = probability of non – occurrence of the same . 
 
STANDARD ERROR OF PROPORTION (S.E.P)  
 
 The probability or Proportional changes of positive or negative occurrence of an attribute 
or a character in a population or universe follows. 
 
 Binomial Frequency Distribution  
      Pq  
      N  
  
Probability of difference occuring by chance can be found by applying Z test as done in 
the case of means,   
                 p – P  
   S.E.P 
 
 
√S.E.P =  
Z =  
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STATISTICAL ANALYSIS OF SUBJECTIVE PARAMETERS OBSERVED 
BEFORE AND AFTER TREATMENT OF PATIENTS. 
 
S.No Parameters 
Percentage improved Statistical 
Criteria 
Probability Significance
Study  Effect Difference 
1. Yellowish 
Discharge  
100 80 20 Z=1.870 P<0.001 Significant  
2. Vulval 
Itching  
83 75 8 Z=0.6451 P<0.001 Significant  
3. Vulval 
Irritation  
75 70 5 Z=0.3225 P<0.001 Significant  
4. Dysuria  62 52 10 Z=1.903 P<0.001 Significant  
 
 
P <0.001 hence the improvement in the subjective parameters produced by Gandaga 
Parpa Mathirai  is statistically significant.  
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DISCUSSION 
 
 Vellai Noi is the term used to describe any white or yellowish – white discharge 
from the vagina. Vellai noi is characterized by itching in vulva, dysuria and yellowish 
discharge. This treatment has become great problem since many women refuse to present 
themselves with such complaints. Hence the disease Vellai Noi was chosen and the drug 
Gandaga Parpa Mathirai was selected for treating Vellai Noi.  
 
 From the literature survey the drug Gandaga Parpa Mathirai was found to be 
more effective in the treatment of Vellai noi. The drug was selected as per the literature 
evidence given in the siddha text “ Sarabendrar Vaidhya Ratnavali”. And clinical trial, 
Pharmacological study were carried out in order to prove its efficacy in the treatment of 
Vellai noi.  
 
The biochemical Analysis of the drug showed the presence of copper and calcium.  
 
 Copper plays vital role in hemopoiesis. If helps in the synthesis of hemoglobin 
and maturation of red blood cells.  
 
"" >VD∏´›>Vu ºƒVˆ ∏›>ﬁ ƒÕWBz ÁkÔ√D  
  TD√VÏ¨ oÔ\Õ>D ÿkıº\ÔD á º>D√wÁÈ  
  Û>ÔºÂVF Aı ˛´Õ] º>V¶∑kV ƒ∫˛Út  
  >VmÂ‚¶ﬁ ÔıºVFº√VD ƒVuÆ ''  
    á z√V¶D, >Vmkz©A  
 
®™ºk ÿƒDA Û>Ô ºÂVFÔÁ·© º√V¬zD.  
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 Calcium ions are necessary for muscle contraction. Muscle contraction is 
impaired when there is a deficiency of calcium ions. Calcium ions are necessary for the 
normal transmission of nerve impulses.  
 
 Phytochemical tests were done which showed the presence of Phytosterol, Protein, 
Tannins, Amino acid, Glycosides.  
 
 Antimicrobial study reveals that the drug is a highly sensitive anti – bacterial agent 
against klebsiella, E.Coli, Pseudomonas, proteus, Staphylococcus aureus and fungi, 
Candida albicans.  
 
 Acute oral toxicity study reveals that the drug  was proved safe for administration 
as it did not exhibit any significant toxicity at 2000 mg/kg body weight.  
  
 Gandaga Parpa Mathirai showed significant analgesic and anti-inflammatory 
activity. The findings of experimental Anti – inflammatory activity was significant and 
this leads pharmacological support to the use of the drug in Vellai not.  
 
 Open clinical trial with  the sample size of 40 patient, for a period of 48 days 
revealed the following features.  
 Maximum No.of Patients affected belong to age group 21-30 (55%) and married 
women (75%) were more compared to unmarried. It was found that improper hygiene 
was the main reason for the disease, so the patients were advised for proper hygiene.  
 Administration of Gandaga Parpa Mathirai, in the dose of 1 tablet (130mg), 
twice daily after food for a period of 48 days showed gradual relief for the subjected 
parameters such as yellowish discharge, itching in vulva, vulva irritation, Dysuria and 
lower abdominal pain.  
 No adverse effects were observed during the course of this study.  
 
 134
SUMMARY 
 
 The study on Gandaga parpa mathirai to evaluate its efficacy in the 
management of Vellai noi was carried out based or the evidences collected from Siddha 
literature. 
 
 After obtaining guidance from the HOD and permission from principle, Govt 
Siddha Medical College, pharmacology study was carried out in C.L.Baid Mehta college 
of pharmacy, Thoraipakkam Chennai. 
 
 The compound drug Gandaga Parpa Mathirai was prepared as per the siddha 
literature. 
 
 Phytochemical tests were done which showed the presence of Alkaloids, 
Phytosterol, Protein, Tannins, Amino acid and Glycosides. 
 
 The antimicrobial study proved it to be effective against various bacteria and 
fungi. Biochemical analysis showed presence of Calcium, Iron (ferrous), Sulphate and 
Chloride. 
 
 Pharmacological study was done for its anti- inflammatory, analgesic activity in 
C.L.Baid Metha college of pharmacy, Chennai, Thoraippakkam. The results showed 
significant Anti inflammatory and analgesic activity. 
 
 The Clinical assessment was done as an open clinical trial in the Gunapadam 
Department op, at Arignar Anna Hospital for Indian Medicine, Chennai – 106, The 
patients were selected according to selection criteria. 
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 Patients were carefully observed in regular visit and prognosis was sincerely 
documented. 
 
 The drug Gandaga parpa mathirai was administered 1 tablet (130mg)  twice a 
day with water (30ml) after food for a period of 48 days. 
 
 In the clinical trial improvement in signs and symptoms like Yellowish discharge, 
Dysuria, Vulval itching, Vulval irritation, lower abdominal pain were clinically 
significant. 
 
 No adverse drug effect was observed during the course of study. 
 
 The drug Gandaga Parpa Mathirai showed significant improvement in the 
treatment of Vellai Noi.  
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CONCLUSION 
 
 The evaluation of efficacy of the compound drug Gandaga parpa mathirai in the 
management of Vellai Noi gave significant results 
 
 Presence of Alkaloids, Phytosterol, Tannins, Amino acid, Glycosides play vital 
role in the management of Vellai Noi. 
 
 Pharmacological anti inflammatory and analgesic activity strengthen the study. 
 
 Clinically the drug relieved the symptoms yellowish discharge dysuria, Vulval 
irritation, Vulval itching very well. 
 
 Gandaga parpa mathirai regularized the 3 humors by stabilizing the Azhal 
thathu by its kaipu, thuvarppu suvai. 
 
 No adverse effects were observed during the period of study. 
 
 In total Gandaga parpa mathirai play a potential therapeutic role in treating 
Vellai Noi. 
 
AGE DISTRIBUTION:  
  
S.No AGE No.of.Cases Percentage  (%) 
1. 11-20 7 17 
2. 21-30 22 55 
3. 31-40 11 27 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INFERENCE  
 Among 40 Patients 7 (17%) were Between 11-20, 22 (55%) were in the age group 
21-30 and 11 (27%) were in the age group 31-40.  
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S.No Occupation  No.of.Cases Percentage  (%) 
1. House Wife  28 70 
2. Students 8 20 
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INFERENCE :  
 
 Among 40 Patients 28 (70%) patients were House wife, 8 (20%) patients were 
students 1(2%) was tailor and 3(7%) patients were Daily Labour.  
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 SOCIO- ECONOMIC STATUS:  
 
S.No Socio – Economic Status  No.of.Cases Percentage  (%) 
1. Poor  26 65 
2. Moderate  10 25 
3. High 4 10 
 
 
 
 
 
 
INFERENCE :  
Among 40 patients 26(65%) were poor, 10(25%) were moderate class and 4 (10%) 
were high people. This data show s that Leucorrhoea is most prevalent in poor people due 
to poor hygienic conditions.  
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Vulval irritation 30 2 28 73 
Itching in Vulva 33 3 30 90 
Lower Abdominal Pain 35 10 25 71 
Low Back Pain 25 10 15 60 
Dysuria 25 4 21 84 
 
 
 
 
 
 
 
 
 
 
INFERENCE:  
 Patients with the parameters that is Yellowish /white discharge, Vulval Irritation, 
Itching in vulva, Lower abdominal pain , Low back pain ,Dysuria  were taken for the 
study.  
Among 40 patients 32 pts improved from Yellowish/ white discharge 
Among 30 patients with Vulval Irritation 28 got relief from the symptom. 
Among 33 patients with Itching in vulva 30 improved. Among 35 patients with Lower 
abdominal pain 25 got relief, Among 25 Patients with  Low back pain 15 got 
improvement, Among 25 Patients with Dysuria  only 21 got improvement.  
MARITAL STATUS  
 
S.No Marital Status No.of Patients Percentage (%) 
MARITAL STATUS 
75%
25%
Married Un Married
1. Married 30 75 
2. Un Married 10 25 
 
 
 
 
 
 
INFERENCE :  
 
 Among 40 patients 30 (75%) patients were married and 10 (25%)  patients were  
unmarried. This shows that the disease is more prevalent in the married women.  
 
 
 
 
 
VAGINAL SMEAR 
 
 
S.No. Vaginal Smear No. of  Patients 
BT AT 
1. Trichomonas Vaginalis (TV) 5 3 
2. Candida albicans 4 3 
3. Non – Specific infections 36 30 
 
INFERENCE:  
Among 40 patients 5 patients were found positive for Trichomonas, 4 were found 
positive Candida albicans and 36 were of Non-specific infections.  
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